{
  "directed": true,
  "graph": {
    "annotation_list": {},
    "annotation_pattern": {
      "Species": "^\\d+$"
    },
    "annotation_url": {
      "Anatomy": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/anatomy/anatomy-20170511.belanno",
      "Cell": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell/cell-20170511.belanno",
      "Confidence": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/confidence/confidence-1.0.0.belanno",
      "Disease": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/disease/disease-20170511.belanno",
      "Gender": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/gender/gender-1.0.0.belanno",
      "MeSHAnatomy": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-anatomy/mesh-anatomy-20170511.belanno",
      "MeSHDisease": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-diseases/mesh-diseases-20170511.belanno"
    },
    "document_metadata": {
      "authors": "Trusha Adeshara",
      "contact": "charles.hoyt@scai.fraunhofer.de",
      "copyright": "Copyright © 2019 Fraunhofer Institute SCAI, All rights reserved.",
      "description": "",
      "licenses": "CC BY 4.0",
      "name": "Immunoneuropsychiatry — novel perspectives on brain disorders",
      "version": "1.0.0"
    },
    "namespace_pattern": {
      "PUBCHEM": "^\\d+$"
    },
    "namespace_url": {
      "CHEBI": "https://raw.githubusercontent.com/pharmacome/terminology/c328ad964c08967a0417a887510b97b965a62fa5/external/chebi-names.belns",
      "CONSO": "https://raw.githubusercontent.com/pharmacome/conso/501ceccdc9a27d97edbdc48a89ebe8e1dd3626e9/export/conso-names.belns",
      "DOID": "https://raw.githubusercontent.com/pharmacome/terminology/c0c576e3d3ab9b25a3982251a4ee2fd7c49e1679/external/doid-names.belns",
      "DRUGBANK": "https://raw.githubusercontent.com/pharmacome/terminology/c328ad964c08967a0417a887510b97b965a62fa5/external/drugbank-names.belns",
      "FB": "https://raw.githubusercontent.com/pharmacome/terminology/c328ad964c08967a0417a887510b97b965a62fa5/external/fb-names.belns",
      "GO": "https://raw.githubusercontent.com/pharmacome/terminology/c328ad964c08967a0417a887510b97b965a62fa5/external/go-names.belns",
      "HGNC": "https://raw.githubusercontent.com/pharmacome/terminology/c328ad964c08967a0417a887510b97b965a62fa5/external/hgnc-names.belns",
      "HGNCGENEFAMILY": "https://raw.githubusercontent.com/pharmacome/terminology/c328ad964c08967a0417a887510b97b965a62fa5/external/hgnc.genefamily-names.belns",
      "HP": "https://raw.githubusercontent.com/pharmacome/conso/d9d270e11aac480542c412d4222983a5f042b8ae/external/hp-names.belns",
      "INTERPRO": "https://raw.githubusercontent.com/pharmacome/terminology/c328ad964c08967a0417a887510b97b965a62fa5/external/interpro-names.belns",
      "MESH": "https://raw.githubusercontent.com/pharmacome/conso/f02c6ad4a4791a8ed45448513b9de8c8f1b00c87/external/mesh-names.belns"
    },
    "path": "inflammasome/pape2019.bel",
    "pybel_version": "0.14.10"
  },
  "links": [
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "Instead, an interplay between neurons, glial cells and the immune system contributes to functional properties, such as cognition, social behaviour and learning performance in the healthy brain.",
      "key": "2561f7a9aa42290f1cdd0165262c72bb",
      "line": 77,
      "relation": "increases",
      "source": 58,
      "target": 68
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "Instead, an interplay between neurons, glial cells and the immune system contributes to functional properties, such as cognition, social behaviour and learning performance in the healthy brain.",
      "key": "acb65efd650ca48741e72be0e38fc260",
      "line": 79,
      "relation": "increases",
      "source": 58,
      "target": 64
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "Instead, an interplay between neurons, glial cells and the immune system contributes to functional properties, such as cognition, social behaviour and learning performance in the healthy brain.",
      "key": "240d8a479c294a87ea9b77d308aea1df",
      "line": 81,
      "relation": "increases",
      "source": 58,
      "target": 69
    },
    {
      "annotations": {
        "Cell": {
          "glial cell": true,
          "neuron": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "Consequently, disturbances in the equilibrium of immune cells, neurons and glial cells needed for healthy CNS function are likely to modify cognitive performance (Fig. 1a).",
      "key": "7c68f51dd5e3eaecf637da8df3429e83",
      "line": 210,
      "relation": "association",
      "source": 68,
      "target": 78
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Inflammation": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "A compelling example of the pathogenic influence of the immune system on brain function is the change in mood, social behaviour and cognitive abilities — known as sickness behaviour — upon infection and systemic inflammation.",
      "key": "8c2e4693572a4ae9e3e7e48637f0d0bc",
      "line": 222,
      "relation": "association",
      "source": 68,
      "target": 78
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Inflammation": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "A compelling example of the pathogenic influence of the immune system on brain function is the change in mood, social behaviour and cognitive abilities — known as sickness behaviour — upon infection and systemic inflammation.",
      "key": "b1926ee67e77847dde8f4193640b6fa5",
      "line": 225,
      "relation": "association",
      "source": 68,
      "target": 175
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Infection": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "Infection can initiate chronic inflammation that alters cognitive function.",
      "key": "be1ef2f5390e072145b29e7f9e8cb652",
      "line": 324,
      "relation": "association",
      "source": 68,
      "target": 198
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "Instead, an interplay between neurons, glial cells and the immune system contributes to functional properties, such as cognition, social behaviour and learning performance in the healthy brain.",
      "key": "9d865399b80c3de17018edc098bfa347",
      "line": 78,
      "relation": "increases",
      "source": 50,
      "target": 68
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "Instead, an interplay between neurons, glial cells and the immune system contributes to functional properties, such as cognition, social behaviour and learning performance in the healthy brain.",
      "key": "5206e49813413bcf8ae35707dc75a4f0",
      "line": 80,
      "relation": "increases",
      "source": 50,
      "target": 64
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "Instead, an interplay between neurons, glial cells and the immune system contributes to functional properties, such as cognition, social behaviour and learning performance in the healthy brain.",
      "key": "635802a39ba8fff3d513042373c8d0ad",
      "line": 82,
      "relation": "increases",
      "source": 50,
      "target": 69
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "Microglia permanently survey their local environment with fine, motile processes 1 and, during brain development, they have an important role in synaptic pruning mediated by the complement proteins C1q and C3, as they phagocytose the complement-tagged synapses 2,3.",
      "key": "ea5fe66063f9e2864dcab47d908de4a6",
      "line": 87,
      "relation": "increases",
      "source": 35,
      "target": 81
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "Microglia permanently survey their local environment with fine, motile processes 1 and, during brain development, they have an important role in synaptic pruning mediated by the complement proteins C1q and C3, as they phagocytose the complement-tagged synapses 2,3.",
      "key": "963a9ab13d63443783415a53b74f0033",
      "line": 89,
      "relation": "increases",
      "source": 35,
      "target": 46
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "In addition to microglia, soluble factors such as chemokines and chemokine receptors also contribute to physiological developmental processes in the CNS; for example, CXC-chemokine receptor 4 (CXCR4) and CXCR7 are involved in the migration of cortical interneurons 4.",
      "key": "0f4ad1901e0b7528eb979f985c3dba5a",
      "line": 96,
      "relation": "increases",
      "source": 35,
      "target": 45
    },
    {
      "annotations": {
        "Anatomy": {
          "central nervous system": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "In the healthy adult brain, microglia have a role in the homeostasis of synaptic circuits in the CNS 5.",
      "key": "cdfee90a25dad55d9acfb76252153f9b",
      "line": 110,
      "relation": "association",
      "source": 35,
      "target": 65
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "In response, microglia can directly contact neurons via outgrowth of processes 5 or can indirectly modulate neuronal firing rate via release of extracellular vesicles 7 or signalling molecules, such as tumour necrosis factor (TNF) 8.",
      "key": "354fdeec3224cb8a8ab8a801433b5bf7",
      "line": 123,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "intracellular",
            "namespace": "bel"
          },
          "toLoc": {
            "name": "extracellular space",
            "namespace": "bel"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "increases",
      "source": 35,
      "target": 14
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "In response, microglia can directly contact neurons via outgrowth of processes 5 or can indirectly modulate neuronal firing rate via release of extracellular vesicles 7 or signalling molecules, such as tumour necrosis factor (TNF) 8.",
      "key": "33fbcd7837fa0bcceac211b13a37d699",
      "line": 124,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "intracellular",
            "namespace": "bel"
          },
          "toLoc": {
            "name": "extracellular space",
            "namespace": "bel"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "increases",
      "source": 35,
      "target": 115
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "In this way, microglia contribute to activity-induced synaptic plasticity, for example, during motor learning and memory.",
      "key": "e2d767d74eb54c8721a6563c85eb3c57",
      "line": 133,
      "relation": "increases",
      "source": 35,
      "target": 61
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "In this way, microglia contribute to activity-induced synaptic plasticity, for example, during motor learning and memory.",
      "key": "81681f8cc6bcf6d8efc8ecce6e65b422",
      "line": 134,
      "relation": "increases",
      "source": 35,
      "target": 55
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "In this way, microglia contribute to activity-induced synaptic plasticity, for example, during motor learning and memory.",
      "key": "527d8f35ed4cd42bcc8fd4a0028d9538",
      "line": 135,
      "relation": "increases",
      "source": 35,
      "target": 52
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "Microglia permanently survey their local environment with fine, motile processes 1 and, during brain development, they have an important role in synaptic pruning mediated by the complement proteins C1q and C3, as they phagocytose the complement-tagged synapses 2,3.",
      "key": "7075245a01494133d8babcfde3c56213",
      "line": 88,
      "relation": "increases",
      "source": 43,
      "target": 46
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "Microglia permanently survey their local environment with fine, motile processes 1 and, during brain development, they have an important role in synaptic pruning mediated by the complement proteins C1q and C3, as they phagocytose the complement-tagged synapses 2,3.",
      "key": "fdef0d480f93836220881a5205c4f5b8",
      "line": 90,
      "relation": "increases",
      "source": 98,
      "target": 46
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "Furthermore, antibodies that cross-react with the NMDA receptor have been found in patients with neuropsychiatric systemic lupus erythematosus, and these antibodies cause neuronal damage via activated microglia and complement component C1q when administered to mice 93,94.",
      "key": "9f8cd4b586cba7fccb191b283ee7f74d",
      "line": 687,
      "object": {
        "modifier": "Degradation"
      },
      "relation": "increases",
      "source": 98,
      "target": 36
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "Microglia permanently survey their local environment with fine, motile processes 1 and, during brain development, they have an important role in synaptic pruning mediated by the complement proteins C1q and C3, as they phagocytose the complement-tagged synapses 2,3.",
      "key": "e82e216ea94460e421dc46e630c6b9b8",
      "line": 91,
      "relation": "increases",
      "source": 99,
      "target": 46
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "In addition to microglia, soluble factors such as chemokines and chemokine receptors also contribute to physiological developmental processes in the CNS; for example, CXC-chemokine receptor 4 (CXCR4) and CXCR7 are involved in the migration of cortical interneurons 4.",
      "key": "8997656ebbb5abf83e86f642c509b304",
      "line": 97,
      "relation": "increases",
      "source": 33,
      "target": 45
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "In addition to microglia, soluble factors such as chemokines and chemokine receptors also contribute to physiological developmental processes in the CNS; for example, CXC-chemokine receptor 4 (CXCR4) and CXCR7 are involved in the migration of cortical interneurons 4.",
      "key": "a8731417714839f5be1007ce99f5ece4",
      "line": 98,
      "relation": "increases",
      "source": 121,
      "target": 45
    },
    {
      "annotations": {
        "Anatomy": {
          "cortex": true
        },
        "Cell": {
          "interneuron": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "In addition to microglia, soluble factors such as chemokines and chemokine receptors also contribute to physiological developmental processes in the CNS; for example, CXC-chemokine receptor 4 (CXCR4) and CXCR7 are involved in the migration of cortical interneurons 4.",
      "key": "e05d209247564d6b6048ca9d46c28921",
      "line": 101,
      "relation": "increases",
      "source": 104,
      "target": 44
    },
    {
      "annotations": {
        "Anatomy": {
          "cortex": true
        },
        "Cell": {
          "interneuron": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "In addition to microglia, soluble factors such as chemokines and chemokine receptors also contribute to physiological developmental processes in the CNS; for example, CXC-chemokine receptor 4 (CXCR4) and CXCR7 are involved in the migration of cortical interneurons 4.",
      "key": "ce9a6e0812bc82b86e389dbc45878cff",
      "line": 102,
      "relation": "increases",
      "source": 97,
      "target": 44
    },
    {
      "annotations": {
        "Anatomy": {
          "central nervous system": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "In the healthy adult brain, microglia have a role in the homeostasis of synaptic circuits in the CNS 5.",
      "key": "0d51541790d9a200b30243c94a32c658",
      "line": 110,
      "relation": "association",
      "source": 65,
      "target": 35
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "Their expression of receptors for purines (such as ATP) and common neurotransmitters (such as glutamate) enables them to sense local neuronal activity 6.",
      "key": "cc5a5ba205972996a1b6dff61db4dad5",
      "line": 117,
      "object": {
        "location": {
          "name": "Microglia",
          "namespace": "MESH"
        }
      },
      "relation": "increases",
      "source": 57,
      "target": 120
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "Their expression of receptors for purines (such as ATP) and common neurotransmitters (such as glutamate) enables them to sense local neuronal activity 6.",
      "key": "9ab2e25ae5a04ccfc393e95eea5ce076",
      "line": 118,
      "object": {
        "location": {
          "name": "Microglia",
          "namespace": "MESH"
        }
      },
      "relation": "increases",
      "source": 57,
      "target": 119
    },
    {
      "annotations": {
        "Cell": {
          "neuron": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "In response, microglia can directly contact neurons via outgrowth of processes 5 or can indirectly modulate neuronal firing rate via release of extracellular vesicles 7 or signalling molecules, such as tumour necrosis factor (TNF) 8.",
      "key": "b5bcbca1242e37450a305aac3d35ba94",
      "line": 126,
      "relation": "increases",
      "source": 14,
      "target": 59
    },
    {
      "annotations": {
        "Cell": {
          "neuron": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "In response, microglia can directly contact neurons via outgrowth of processes 5 or can indirectly modulate neuronal firing rate via release of extracellular vesicles 7 or signalling molecules, such as tumour necrosis factor (TNF) 8.",
      "key": "3e56975ffcf01af0c7d092c9fa4e3035",
      "line": 127,
      "relation": "increases",
      "source": 115,
      "target": 59
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Inflammation": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "The release of pro-inflammatory cytokines, such as IL-1β, IL-6 and TNF, outside the CNS affects the brain via neural (mainly vagal) pathways, interaction with cytokine receptors on cerebral endothelial cells and/or microglial activation 26.",
      "key": "72e17b77349ea297096abb2ed06c5c2e",
      "line": 234,
      "relation": "increases",
      "source": 115,
      "target": 19
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Inflammation": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "The release of pro-inflammatory cytokines, such as IL-1β, IL-6 and TNF, outside the CNS affects the brain via neural (mainly vagal) pathways, interaction with cytokine receptors on cerebral endothelial cells and/or microglial activation 26.",
      "key": "2a50315c86863536ff0e7fb987c2a680",
      "line": 241,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 115,
      "target": 35
    },
    {
      "annotations": {
        "Anatomy": {
          "cerebral cortex": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "Our recent studies indicate that the cortical network responds to an inflammatory attack with a TNF-dependent increase in cortical synaptic strength 65.",
      "key": "fcb37998361aa825dc93f325e2ee065d",
      "line": 870,
      "relation": "increases",
      "source": 115,
      "target": 23
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "During systemic inflammation, microglia can become activated and produce pro-inflammatory mediators and induce phagocytosis 9.",
      "key": "354c4d02e1a8f14bb14fe46edc129e79",
      "line": 140,
      "relation": "increases",
      "source": 51,
      "target": 53
    },
    {
      "annotations": {
        "Anatomy": {
          "choroid plexus": true,
          "peripheral nervous system": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "Notably, evidence suggests that the choroid plexus has a role not only in transmigration but also in stimulation of T cells in response to peripheral inflammatory signals 13.",
      "key": "05b53ba96eed43e51501230f153b20a0",
      "line": 157,
      "relation": "increases",
      "source": 51,
      "target": 83
    },
    {
      "annotations": {
        "Anatomy": {
          "choroid plexus": true,
          "peripheral nervous system": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "Notably, evidence suggests that the choroid plexus has a role not only in transmigration but also in stimulation of T cells in response to peripheral inflammatory signals 13.",
      "key": "10e3bfb81ece95b986c317c4a1f1aa75",
      "line": 158,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 51,
      "target": 24
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "During systemic inflammation, microglia can become activated and produce pro-inflammatory mediators and induce phagocytosis 9.",
      "key": "2f9a4c877287b143788e7a9f7a8824ff",
      "line": 141,
      "relation": "increases",
      "source": 53,
      "target": 18
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "During systemic inflammation, microglia can become activated and produce pro-inflammatory mediators and induce phagocytosis 9.",
      "key": "9eae65a3f5f100b25db7b1dd8238e692",
      "line": 142,
      "relation": "increases",
      "source": 53,
      "target": 72
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "In this way, both innate (microglial activation with subsequent phagocytosis or cytokine production) and adaptive immune responses (antigen-specific responsiveness and production of antibodies) contribute to pathology.",
      "key": "ca33d0f53cfc266ca556c7c020db9cae",
      "line": 437,
      "relation": "increases",
      "source": 53,
      "target": 72
    },
    {
      "annotations": {
        "Cell": {
          "neuron": true
        },
        "Confidence": {
          "High": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "In addition, extracellular deposits of Aβ activate resting microglia and trigger them to attack neurons via various pathways, such as NADPH oxidase activation, inducible nitric oxide synthase expression and phagocytosis 60.",
      "key": "2fd53864806f237acc1e922fac2fc50f",
      "line": 509,
      "relation": "increases",
      "source": 53,
      "target": 72
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "In this way, both innate (microglial activation with subsequent phagocytosis or cytokine production) and adaptive immune responses (antigen-specific responsiveness and production of antibodies) contribute to pathology.",
      "key": "99759bbf7a0a763316ab65bca3ce829f",
      "line": 438,
      "relation": "increases",
      "source": 53,
      "target": 47
    },
    {
      "annotations": {
        "Cell": {
          "neuron": true
        },
        "Confidence": {
          "High": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "In addition, extracellular deposits of Aβ activate resting microglia and trigger them to attack neurons via various pathways, such as NADPH oxidase activation, inducible nitric oxide synthase expression and phagocytosis 60.",
      "key": "67c77c8672b2266d516a158db53507e3",
      "line": 507,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 53,
      "target": 122
    },
    {
      "annotations": {
        "Cell": {
          "neuron": true
        },
        "Confidence": {
          "High": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "In addition, extracellular deposits of Aβ activate resting microglia and trigger them to attack neurons via various pathways, such as NADPH oxidase activation, inducible nitric oxide synthase expression and phagocytosis 60.",
      "key": "7ca474e0799caba39300696f76a01d5c",
      "line": 508,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 53,
      "target": 88
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "Furthermore, antibodies that cross-react with the NMDA receptor have been found in patients with neuropsychiatric systemic lupus erythematosus, and these antibodies cause neuronal damage via activated microglia and complement component C1q when administered to mice 93,94.",
      "key": "3242cc5a7ed0ceb1a0790a87584ed8c1",
      "line": 686,
      "object": {
        "modifier": "Degradation"
      },
      "relation": "increases",
      "source": 53,
      "target": 36
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "For example, genetic defects in microglial signalling pathways cause abnormal development of brain circuits and neuropsychiatric symptoms, as in hereditary diffuse leukoencephalopathy with spheroids (HDLS) 109.",
      "key": "fcf9000fb3fbac6533653939a2ae836e",
      "line": 724,
      "relation": "negativeCorrelation",
      "source": 53,
      "target": 174
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "For example, genetic defects in microglial signalling pathways cause abnormal development of brain circuits and neuropsychiatric symptoms, as in hereditary diffuse leukoencephalopathy with spheroids (HDLS) 109.",
      "key": "1d3b003c30c3040d37bd068dd445d305",
      "line": 725,
      "relation": "increases",
      "source": 53,
      "target": 19
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "Some evidence suggests that the association between psychiatric disorders and stress is mediated, at least in part, by neuroinflammatory processes, including microglial activation.",
      "key": "ed7e58b2a0ed77864cdaee1ec8b36aa2",
      "line": 850,
      "relation": "increases",
      "source": 53,
      "target": 56
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "In this way, both innate (microglial activation with subsequent phagocytosis or cytokine production) and adaptive immune responses (antigen-specific responsiveness and production of antibodies) contribute to pathology.",
      "key": "b13492c95f7354b04c73b09f3e000ca3",
      "line": 439,
      "relation": "increases",
      "source": 72,
      "target": 41
    },
    {
      "annotations": {
        "Anatomy": {
          "brain": true,
          "brain meninx": true,
          "cerebrospinal fluid": true,
          "choroid plexus": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "However, in healthy individuals, antigen-presenting cells and T cells patrol the brain’s borders, residing in the meninges, the choroid plexus and the cerebro spinal fluid (CSF) 10.",
      "key": "4c11849d6a236238a18d7db4f6751402",
      "line": 148,
      "relation": "increases",
      "source": 8,
      "target": 81
    },
    {
      "annotations": {
        "Anatomy": {
          "brain": true,
          "brain meninx": true,
          "cerebrospinal fluid": true,
          "choroid plexus": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "However, in healthy individuals, antigen-presenting cells and T cells patrol the brain’s borders, residing in the meninges, the choroid plexus and the cerebro spinal fluid (CSF) 10.",
      "key": "0fab61f64b531c46b70b56f218fb990b",
      "line": 149,
      "relation": "increases",
      "source": 24,
      "target": 81
    },
    {
      "annotations": {
        "Anatomy": {
          "parenchyma of central nervous system": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "Although T cells do not generally penetrate the parenchyma in non-inflammatory conditions, they can release soluble cytokines that affect CNS function 14,15.",
      "key": "baee69b1fb46255bcd7e72bfb65b8019",
      "line": 165,
      "relation": "increases",
      "source": 24,
      "target": 48
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "Studies in mice have demonstrated that adaptive immunity is necessary for cognitive performance: mice with severe combined immune deficiency exhibited impaired spatial learning and memory, but symptoms were reversed by injection of exogenous T cells 16.",
      "key": "673c82af99a70a7514193d0306d899e4",
      "line": 175,
      "relation": "increases",
      "source": 24,
      "target": 52
    },
    {
      "annotations": {
        "Anatomy": {
          "parenchyma of central nervous system": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "Although T cells do not generally penetrate the parenchyma in non-inflammatory conditions, they can release soluble cytokines that affect CNS function 14,15.",
      "key": "41d5c3eb606498f8ceeb61517a3cd879",
      "line": 166,
      "object": {
        "modifier": "Activity"
      },
      "relation": "association",
      "source": 48,
      "target": 12
    },
    {
      "annotations": {
        "Anatomy": {
          "parenchyma of central nervous system": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "Although T cells do not generally penetrate the parenchyma in non-inflammatory conditions, they can release soluble cytokines that affect CNS function 14,15.",
      "key": "52c526e329a7943646f50b42101793d7",
      "line": 166,
      "relation": "association",
      "source": 12,
      "subject": {
        "modifier": "Activity"
      },
      "target": 48
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "Studies in mice have demonstrated that adaptive immunity is necessary for cognitive performance: mice with severe combined immune deficiency exhibited impaired spatial learning and memory, but symptoms were reversed by injection of exogenous T cells 16.",
      "key": "cb14e375e32f5eb9e4e089c920591888",
      "line": 173,
      "relation": "increases",
      "source": 74,
      "target": 68
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "Studies in mice have demonstrated that adaptive immunity is necessary for cognitive performance: mice with severe combined immune deficiency exhibited impaired spatial learning and memory, but symptoms were reversed by injection of exogenous T cells 16.",
      "key": "4fefec065eea5df95ca5ef1d7b8fad72",
      "line": 174,
      "relation": "increases",
      "source": 74,
      "target": 52
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "In this way, both innate (microglial activation with subsequent phagocytosis or cytokine production) and adaptive immune responses (antigen-specific responsiveness and production of antibodies) contribute to pathology.",
      "key": "16aecd44173ce2f405f6b8442b70fee4",
      "line": 444,
      "relation": "increases",
      "source": 74,
      "target": 200
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "From a neurobiological perspective, levels of neurogenesis in adult transgenic mice that overexpress a CNS-specific T cell receptor are higher than those in mice that overexpress a T cell receptor for a non-CNS-specific antigen 17.",
      "key": "d0f2656228d20d76962a1d4343c73b15",
      "line": 180,
      "relation": "increases",
      "source": 124,
      "target": 70
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "Further beneficial roles of the immune response in the CNS — again going against the anticipated pathogenic activity of inflammation — include protective roles for T helper 2 (TH2) cells in CNS injury and for IL-4 signalling in neurons in multiple sclerosis (MS) models 18,19.",
      "key": "4eb1099f895d16e10caccabed1c528bb",
      "line": 186,
      "relation": "association",
      "source": 28,
      "target": 171
    },
    {
      "annotations": {
        "Cell": {
          "neuron": true
        },
        "Confidence": {
          "High": true
        },
        "Disease": {
          "multiple sclerosis": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "Further beneficial roles of the immune response in the CNS — again going against the anticipated pathogenic activity of inflammation — include protective roles for T helper 2 (TH2) cells in CNS injury and for IL-4 signalling in neurons in multiple sclerosis (MS) models 18,19.",
      "key": "4670386f774ba8592ae26f4fb52a0c66",
      "line": 189,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 28,
      "target": 110
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "Further beneficial roles of the immune response in the CNS — again going against the anticipated pathogenic activity of inflammation — include protective roles for T helper 2 (TH2) cells in CNS injury and for IL-4 signalling in neurons in multiple sclerosis (MS) models 18,19.",
      "key": "3f4fff3ccb201a25c51fafab70869b17",
      "line": 186,
      "relation": "association",
      "source": 171,
      "target": 28
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "The complex and diverse roles of adaptive immune cells are further underlined by the finding that a lack of B cells does not impair learning behaviour in mice 20.",
      "key": "490b0dbeed034dc05d782b5a1f952623",
      "line": 197,
      "relation": "causesNoChange",
      "source": 9,
      "target": 52
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "Cytokine signalling is not the only aspect of maternal immunity that affects the developing fetal brain — B cell-mediated immune responses and production of antibodies can also have effects.",
      "key": "56c4c4348ecd11f931539f738d8591b9",
      "line": 776,
      "relation": "association",
      "source": 9,
      "subject": {
        "modifier": "Activity"
      },
      "target": 49
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "Activation of the glymphatic system is higher during sleep than during wakefulness, underlining the importance of sleep for removal of potentially neurotoxic waste products 22.",
      "key": "fcdd0c53164a446b1cd81de65e211ad4",
      "line": 203,
      "relation": "decreases",
      "source": 85,
      "target": 29
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "Activation of the glymphatic system is higher during sleep than during wakefulness, underlining the importance of sleep for removal of potentially neurotoxic waste products 22.",
      "key": "f3e0f0fc61dfc83a2051f3a8c7642dbd",
      "line": 204,
      "relation": "decreases",
      "source": 85,
      "target": 130
    },
    {
      "annotations": {
        "Cell": {
          "glial cell": true,
          "neuron": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "Consequently, disturbances in the equilibrium of immune cells, neurons and glial cells needed for healthy CNS function are likely to modify cognitive performance (Fig. 1a).",
      "key": "9d06656cb41b673143f2dd50c13d1c0a",
      "line": 210,
      "relation": "association",
      "source": 78,
      "target": 68
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Inflammation": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "A compelling example of the pathogenic influence of the immune system on brain function is the change in mood, social behaviour and cognitive abilities — known as sickness behaviour — upon infection and systemic inflammation.",
      "key": "dc751d19b26c9c645b466a13196e9c41",
      "line": 222,
      "relation": "association",
      "source": 78,
      "target": 68
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Inflammation": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "A compelling example of the pathogenic influence of the immune system on brain function is the change in mood, social behaviour and cognitive abilities — known as sickness behaviour — upon infection and systemic inflammation.",
      "key": "ba9a04e58e94cec210285f97a58efea2",
      "line": 220,
      "relation": "association",
      "source": 78,
      "target": 178
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Inflammation": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "A compelling example of the pathogenic influence of the immune system on brain function is the change in mood, social behaviour and cognitive abilities — known as sickness behaviour — upon infection and systemic inflammation.",
      "key": "21cd38506599f75b9c02ac8ab988a8a1",
      "line": 221,
      "relation": "association",
      "source": 78,
      "target": 189
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Inflammation": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "A compelling example of the pathogenic influence of the immune system on brain function is the change in mood, social behaviour and cognitive abilities — known as sickness behaviour — upon infection and systemic inflammation.",
      "key": "74d0780c55caa1e188f7aaa49896748a",
      "line": 226,
      "relation": "association",
      "source": 78,
      "target": 175
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "Autoimmune responses can be antibody driven or cell driven and, depending on the autoantigen involved, can involve antigen presentation by major histocompatibility complex (MHC) class II.",
      "key": "57da151404f399e0c1502e428d75bcb1",
      "line": 522,
      "relation": "increases",
      "source": 78,
      "target": 163
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Inflammation": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "A compelling example of the pathogenic influence of the immune system on brain function is the change in mood, social behaviour and cognitive abilities — known as sickness behaviour — upon infection and systemic inflammation.",
      "key": "1ad24f3e42c1a07adb4937f78d20120e",
      "line": 218,
      "relation": "increases",
      "source": 192,
      "target": 175
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Inflammation": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "A compelling example of the pathogenic influence of the immune system on brain function is the change in mood, social behaviour and cognitive abilities — known as sickness behaviour — upon infection and systemic inflammation.",
      "key": "7001cacc3e0e0f46b59262ed56f4744b",
      "line": 223,
      "relation": "increases",
      "source": 175,
      "target": 178
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Inflammation": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "A compelling example of the pathogenic influence of the immune system on brain function is the change in mood, social behaviour and cognitive abilities — known as sickness behaviour — upon infection and systemic inflammation.",
      "key": "499244fdd6a4f4eba1a67cdfec404114",
      "line": 224,
      "relation": "increases",
      "source": 175,
      "target": 188
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Inflammation": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "A compelling example of the pathogenic influence of the immune system on brain function is the change in mood, social behaviour and cognitive abilities — known as sickness behaviour — upon infection and systemic inflammation.",
      "key": "cd2067ba66f7986b832452c41a03d047",
      "line": 225,
      "relation": "association",
      "source": 175,
      "target": 68
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Inflammation": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "A compelling example of the pathogenic influence of the immune system on brain function is the change in mood, social behaviour and cognitive abilities — known as sickness behaviour — upon infection and systemic inflammation.",
      "key": "10fce134cfd20a3985afeff18514f443",
      "line": 226,
      "relation": "association",
      "source": 175,
      "target": 78
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Inflammation": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "A compelling example of the pathogenic influence of the immune system on brain function is the change in mood, social behaviour and cognitive abilities — known as sickness behaviour — upon infection and systemic inflammation.",
      "key": "421537125b85479987961e8f7d4657bb",
      "line": 219,
      "relation": "increases",
      "source": 197,
      "target": 175
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Inflammation": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "Chronic inflammation is implicated in schizophrenia and other psychiatric disorders 32, and systemic inflammation, as well as acute infections, have been associated with an increased rate of cognitive decline and exacerbation of symptoms in patients with Alzheimer disease (AD) 33.",
      "key": "808ce33031cb638b10075290321ec103",
      "line": 286,
      "relation": "decreases",
      "source": 197,
      "target": 68
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Fetus": true
        },
        "MeSHDisease": {
          "Infection": true
        },
        "Species": {
          "9989": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "In rodents, even infection and systemic inflammation in the fetus during the prenatal or perinatal period can cause long-term cognitive damage, including learning, memory and attention abnormalities, a model that explains why early infection increases the risk of psychosis in young adulthood 38,39.",
      "key": "517f06f882f7cb856e16793c86227947",
      "line": 333,
      "relation": "decreases",
      "source": 197,
      "target": 68
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "In the prospective Northern Manhattan Study, a high infectious burden (assessed with serological markers for Chlamydia pneumoniae, Helicobacter pylori, CMV, HSV-1 and HSV-2) was associated with cognitive decline independently of cardiovascular risk among a cohort of 1,625 patients 49.",
      "key": "57d1aac890ce65afb04c3361b5fcda02",
      "line": 401,
      "relation": "decreases",
      "source": 197,
      "target": 68
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Disease": {
          "Alzheimer's disease": true
        },
        "MeSHDisease": {
          "Inflammation": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "Chronic inflammation is implicated in schizophrenia and other psychiatric disorders 32, and systemic inflammation, as well as acute infections, have been associated with an increased rate of cognitive decline and exacerbation of symptoms in patients with Alzheimer disease (AD) 33.",
      "key": "9cf2d1c6189c7c8001a5631abd4bb3d9",
      "line": 289,
      "relation": "increases",
      "source": 197,
      "target": 187
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Infection": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "Infection can initiate chronic inflammation that alters cognitive function.",
      "key": "af6b75346c185c6539b6c0e1946b4ff8",
      "line": 323,
      "relation": "increases",
      "source": 197,
      "target": 198
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Fetus": true
        },
        "MeSHDisease": {
          "Infection": true
        },
        "Species": {
          "9989": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "In rodents, even infection and systemic inflammation in the fetus during the prenatal or perinatal period can cause long-term cognitive damage, including learning, memory and attention abnormalities, a model that explains why early infection increases the risk of psychosis in young adulthood 38,39.",
      "key": "951b8722834a8d12f7bc13b4ffd0e162",
      "line": 335,
      "relation": "increases",
      "source": 197,
      "target": 135
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Fetus": true
        },
        "MeSHDisease": {
          "Infection": true
        },
        "Species": {
          "9989": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "In rodents, even infection and systemic inflammation in the fetus during the prenatal or perinatal period can cause long-term cognitive damage, including learning, memory and attention abnormalities, a model that explains why early infection increases the risk of psychosis in young adulthood 38,39.",
      "key": "1c989999052beec9e9e3780f004fcc4b",
      "line": 337,
      "relation": "decreases",
      "source": 197,
      "target": 52
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Fetus": true
        },
        "MeSHDisease": {
          "Infection": true
        },
        "Species": {
          "9989": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "In rodents, even infection and systemic inflammation in the fetus during the prenatal or perinatal period can cause long-term cognitive damage, including learning, memory and attention abnormalities, a model that explains why early infection increases the risk of psychosis in young adulthood 38,39.",
      "key": "5ac430fe17ee32e73f0522e9d159bb9d",
      "line": 339,
      "relation": "decreases",
      "source": 197,
      "target": 194
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Disease": {
          "viral infectious disease": true
        },
        "MeSHDisease": {
          "Infection": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "Similarly, a viral infection in the mother during the first trimester of pregnancy and bacterial infection during the second trimester of pregnancy were associated with the development of autism spectrum disorder (ASD), a pervasive neurodevelopmental disorder defined by impairments in social skills and stereotypical behaviour, among the children in a large Danish cohort 40.",
      "key": "8abfa0e5a7ab1b31392dc7226bc6a7a0",
      "line": 348,
      "relation": "increases",
      "source": 197,
      "target": 133
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Multiple Sclerosis": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "Relapses in patients with MS are influenced by stressful life events and by infections: a systematic meta-analysis has shown that upper respiratory tract infections have the most pronounced effect on relapse rates 74.",
      "key": "d747398ea4579143965712871299049d",
      "line": 591,
      "relation": "increases",
      "source": 197,
      "target": 202
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Inflammation": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "A compelling example of the pathogenic influence of the immune system on brain function is the change in mood, social behaviour and cognitive abilities — known as sickness behaviour — upon infection and systemic inflammation.",
      "key": "21a668221edced5bf39f7606a95b25ab",
      "line": 220,
      "relation": "association",
      "source": 178,
      "target": 78
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Inflammation": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "A compelling example of the pathogenic influence of the immune system on brain function is the change in mood, social behaviour and cognitive abilities — known as sickness behaviour — upon infection and systemic inflammation.",
      "key": "bd07cbe6535c4b4545ed1b57d6692bce",
      "line": 221,
      "relation": "association",
      "source": 189,
      "target": 78
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Inflammation": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "The behavioural effects, such as social withdrawal and fatigue, are assumed to be adaptive responses that increase survival of the host 27.",
      "key": "c04223b4aae40ed29c1eabbd5192afaf",
      "line": 246,
      "relation": "increases",
      "source": 188,
      "target": 86
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Inflammation": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "The release of pro-inflammatory cytokines, such as IL-1β, IL-6 and TNF, outside the CNS affects the brain via neural (mainly vagal) pathways, interaction with cytokine receptors on cerebral endothelial cells and/or microglial activation 26.",
      "key": "8b9bca2301824fe60088d6ddf7a31356",
      "line": 232,
      "relation": "increases",
      "source": 108,
      "target": 19
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Inflammation": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "The release of pro-inflammatory cytokines, such as IL-1β, IL-6 and TNF, outside the CNS affects the brain via neural (mainly vagal) pathways, interaction with cytokine receptors on cerebral endothelial cells and/or microglial activation 26.",
      "key": "c1a630190b03b2ac2c5ec4564d6d8af1",
      "line": 239,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 108,
      "target": 35
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "Furthermore, extensive studies of cytokine profiles in disorders such as schizophrenia, depression, suicidal ideation and post-traumatic stress disorder reveal wide-ranging dysregulation of mainly pro-inflammatory markers, in particular IL-6, IL-2 receptor, IL-1β, IL-17 A and C-reactive protein (CRP) 103–107.",
      "key": "bb62d2b789701d0a4e82da3e0dc6eed1",
      "line": 700,
      "relation": "negativeCorrelation",
      "source": 108,
      "target": 151
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "Furthermore, extensive studies of cytokine profiles in disorders such as schizophrenia, depression, suicidal ideation and post-traumatic stress disorder reveal wide-ranging dysregulation of mainly pro-inflammatory markers, in particular IL-6, IL-2 receptor, IL-1β, IL-17 A and C-reactive protein (CRP) 103–107.",
      "key": "9362c1dce49c5c72a9ae94210b585355",
      "line": 705,
      "relation": "negativeCorrelation",
      "source": 108,
      "target": 136
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "Furthermore, extensive studies of cytokine profiles in disorders such as schizophrenia, depression, suicidal ideation and post-traumatic stress disorder reveal wide-ranging dysregulation of mainly pro-inflammatory markers, in particular IL-6, IL-2 receptor, IL-1β, IL-17 A and C-reactive protein (CRP) 103–107.",
      "key": "3c12910903c6fb69f75e321bde57c162",
      "line": 710,
      "relation": "negativeCorrelation",
      "source": 108,
      "target": 141
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Inflammation": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "The release of pro-inflammatory cytokines, such as IL-1β, IL-6 and TNF, outside the CNS affects the brain via neural (mainly vagal) pathways, interaction with cytokine receptors on cerebral endothelial cells and/or microglial activation 26.",
      "key": "0ca97e3da0fa60b965ce8457a2d2b42a",
      "line": 235,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 19,
      "target": 32
    },
    {
      "annotations": {
        "Anatomy": {
          "cerebral cortex": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "Our recent studies indicate that the cortical network responds to an inflammatory attack with a TNF-dependent increase in cortical synaptic strength 65.",
      "key": "a892efce895c0121e1694fec23f7351d",
      "line": 869,
      "relation": "increases",
      "source": 19,
      "target": 115
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Inflammation": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "The release of pro-inflammatory cytokines, such as IL-1β, IL-6 and TNF, outside the CNS affects the brain via neural (mainly vagal) pathways, interaction with cytokine receptors on cerebral endothelial cells and/or microglial activation 26.",
      "key": "e59b8d275d6630bc7467f259af07251d",
      "line": 233,
      "relation": "increases",
      "source": 111,
      "target": 19
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Inflammation": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "The release of pro-inflammatory cytokines, such as IL-1β, IL-6 and TNF, outside the CNS affects the brain via neural (mainly vagal) pathways, interaction with cytokine receptors on cerebral endothelial cells and/or microglial activation 26.",
      "key": "1b1df61137ea7d42bbc02a1ee0dfa464",
      "line": 240,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 111,
      "target": 35
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "Furthermore, extensive studies of cytokine profiles in disorders such as schizophrenia, depression, suicidal ideation and post-traumatic stress disorder reveal wide-ranging dysregulation of mainly pro-inflammatory markers, in particular IL-6, IL-2 receptor, IL-1β, IL-17 A and C-reactive protein (CRP) 103–107.",
      "key": "4c1c9c088e34d978b5dedce14ac08d88",
      "line": 698,
      "relation": "negativeCorrelation",
      "source": 111,
      "target": 151
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "Furthermore, extensive studies of cytokine profiles in disorders such as schizophrenia, depression, suicidal ideation and post-traumatic stress disorder reveal wide-ranging dysregulation of mainly pro-inflammatory markers, in particular IL-6, IL-2 receptor, IL-1β, IL-17 A and C-reactive protein (CRP) 103–107.",
      "key": "c771f83b78d3e1166b5b304a1faf547a",
      "line": 703,
      "relation": "negativeCorrelation",
      "source": 111,
      "target": 136
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "Furthermore, extensive studies of cytokine profiles in disorders such as schizophrenia, depression, suicidal ideation and post-traumatic stress disorder reveal wide-ranging dysregulation of mainly pro-inflammatory markers, in particular IL-6, IL-2 receptor, IL-1β, IL-17 A and C-reactive protein (CRP) 103–107.",
      "key": "a942f3f957b58169d664bc6465a0a535",
      "line": 708,
      "relation": "negativeCorrelation",
      "source": 111,
      "target": 141
    },
    {
      "annotations": {
        "Anatomy": {
          "embryonic brain": true
        },
        "Confidence": {
          "High": true
        },
        "Species": {
          "10116": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "In this model, IL-6 was identified as a key mediator of inflammatory effects on fetal brain development 114.",
      "key": "19e5f91a23f4abe32e63defb468c7189",
      "line": 744,
      "relation": "regulates",
      "source": 111,
      "target": 198
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "In mice, autism-like behaviour in offspring requires the presence of maternal RORgammat-positive TH17 cells and IL-17a downstream of IL-6 (reF.115).",
      "key": "c96de637e54aa66569eca325e2d5dfe7",
      "line": 753,
      "relation": "increases",
      "source": 111,
      "target": 107
    },
    {
      "annotations": {
        "Cell": {
          "cerebral cortex endothelial cell": true
        },
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Inflammation": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "The release of pro-inflammatory cytokines, such as IL-1β, IL-6 and TNF, outside the CNS affects the brain via neural (mainly vagal) pathways, interaction with cytokine receptors on cerebral endothelial cells and/or microglial activation 26.",
      "key": "be5d6eb7894e3e6a1a13cc4e0ca171b7",
      "line": 237,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 125,
      "target": 32
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Inflammation": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "The behavioural effects, such as social withdrawal and fatigue, are assumed to be adaptive responses that increase survival of the host 27.",
      "key": "f173c6fd835e8d3e85e36a64c7b92707",
      "line": 247,
      "relation": "increases",
      "source": 164,
      "target": 86
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Disease": {
          "multiple sclerosis": true,
          "viral hepatitis": true
        },
        "MeSHDisease": {
          "Inflammation": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "Similarly, treatment with the cytokine IFNβ, for MS or chronic viral hepatitis, for example, has been associated with depressive symptoms as an adverse effect 28.",
      "key": "c48825f7fae5c544d1975b81bec51c7c",
      "line": 253,
      "relation": "increases",
      "source": 106,
      "target": 136
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "In mice, recurrent asymptomatic activation of HSV-1 leads to upregulation of markers of neuroinflammation (for example, Toll-like receptor-4, IFNα and IFNβ) and early neurodegeneration 59.",
      "key": "eb44e308ecf4ea9997d197b661c2b06c",
      "line": 497,
      "relation": "biomarkerFor",
      "source": 106,
      "target": 129
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "In mice, recurrent asymptomatic activation of HSV-1 leads to upregulation of markers of neuroinflammation (for example, Toll-like receptor-4, IFNα and IFNβ) and early neurodegeneration 59.",
      "key": "c658b66f349ce8c6b9b8dc9b5acc66d9",
      "line": 500,
      "relation": "biomarkerFor",
      "source": 106,
      "target": 128
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "Furthermore, extensive studies of cytokine profiles in disorders such as schizophrenia, depression, suicidal ideation and post-traumatic stress disorder reveal wide-ranging dysregulation of mainly pro-inflammatory markers, in particular IL-6, IL-2 receptor, IL-1β, IL-17 A and C-reactive protein (CRP) 103–107.",
      "key": "2c6967af98189459c6988c295b0c62b0",
      "line": 703,
      "relation": "negativeCorrelation",
      "source": 136,
      "target": 111
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "Furthermore, extensive studies of cytokine profiles in disorders such as schizophrenia, depression, suicidal ideation and post-traumatic stress disorder reveal wide-ranging dysregulation of mainly pro-inflammatory markers, in particular IL-6, IL-2 receptor, IL-1β, IL-17 A and C-reactive protein (CRP) 103–107.",
      "key": "b976c370f0d5d26886f78d56ee613353",
      "line": 704,
      "relation": "negativeCorrelation",
      "source": 136,
      "target": 109
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "Furthermore, extensive studies of cytokine profiles in disorders such as schizophrenia, depression, suicidal ideation and post-traumatic stress disorder reveal wide-ranging dysregulation of mainly pro-inflammatory markers, in particular IL-6, IL-2 receptor, IL-1β, IL-17 A and C-reactive protein (CRP) 103–107.",
      "key": "b6b514257f7582084611e317e33a64dc",
      "line": 705,
      "relation": "negativeCorrelation",
      "source": 136,
      "target": 108
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "Furthermore, extensive studies of cytokine profiles in disorders such as schizophrenia, depression, suicidal ideation and post-traumatic stress disorder reveal wide-ranging dysregulation of mainly pro-inflammatory markers, in particular IL-6, IL-2 receptor, IL-1β, IL-17 A and C-reactive protein (CRP) 103–107.",
      "key": "27a85730497b95f24015a052a1ac8f71",
      "line": 706,
      "relation": "negativeCorrelation",
      "source": 136,
      "target": 107
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "Furthermore, extensive studies of cytokine profiles in disorders such as schizophrenia, depression, suicidal ideation and post-traumatic stress disorder reveal wide-ranging dysregulation of mainly pro-inflammatory markers, in particular IL-6, IL-2 receptor, IL-1β, IL-17 A and C-reactive protein (CRP) 103–107.",
      "key": "b8b2f88f15f716375c132198f25b01c2",
      "line": 707,
      "relation": "negativeCorrelation",
      "source": 136,
      "target": 103
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Hippocampus": true
        },
        "MeSHDisease": {
          "Stress, Psychological": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "For example, in a mouse model, chronic stress with depressive behaviour has been associated with microglial loss in the hippocampus 110.",
      "key": "0b15faf30181a025aa072aa8aac25de4",
      "line": 733,
      "object": {
        "modifier": "Degradation"
      },
      "relation": "increases",
      "source": 136,
      "target": 35
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Species": {
          "10116": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "In rats, the microglia inhibitor minocycline improved symptoms of depression in the forced swimming test 143, an observation that is consistent with reports that microglia are overactivated in depression 112.",
      "key": "527c5515946bb70143a2d65b53fb6f3e",
      "line": 823,
      "relation": "increases",
      "source": 136,
      "target": 35
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "Furthermore, in depression, anti-inflammatory treatment with the TNF antagonist infliximab had beneficial effects in patients with treatment-resistant depression and high baseline levels of inflammatory biomarkers 147.",
      "key": "bcdd163453eee53406078e9b9129d998",
      "line": 838,
      "relation": "negativeCorrelation",
      "source": 136,
      "target": 39
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Inflammation": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": " Sickness behaviour can be diminished after repeated subthreshold exposure to pathogens, a mechanism that is referred to as euflammation and that evidence suggests is the result of tolerogenic processes 29.",
      "key": "017dae865b6ccd4a10e27ca28c0478ce",
      "line": 259,
      "relation": "decreases",
      "source": 20,
      "target": 175
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Inflammation": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "In contrast to this transient low-grade inflammation, chronic low-grade inflammation can occur and cause neurotoxicity and neurodegeneration 30.",
      "key": "938a41624181d84cab0819ac28900f9b",
      "line": 266,
      "relation": "increases",
      "source": 198,
      "target": 130
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Inflammation": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "In contrast to this transient low-grade inflammation, chronic low-grade inflammation can occur and cause neurotoxicity and neurodegeneration 30.",
      "key": "3fce2fcdbad7b96c139d3e441b829952",
      "line": 267,
      "relation": "increases",
      "source": 198,
      "target": 128
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Inflammation": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "Chronic inflammation is implicated in schizophrenia and other psychiatric disorders 32, and systemic inflammation, as well as acute infections, have been associated with an increased rate of cognitive decline and exacerbation of symptoms in patients with Alzheimer disease (AD) 33.",
      "key": "118caff1ae4213bf72daebded8503c97",
      "line": 285,
      "relation": "decreases",
      "source": 198,
      "target": 68
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Inflammation": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "Chronic low-grade inflammation is also present in people who are obese 34, and this inflammation influences cognitive performance by damaging neuronal circuits and the BBB and by activating pro-inflammatory immune cells 35.",
      "key": "7a356c07dbe1446da504483388c542c2",
      "line": 297,
      "relation": "decreases",
      "source": 198,
      "target": 68
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Infection": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "Infection can initiate chronic inflammation that alters cognitive function.",
      "key": "6d704e4b5c40106eaba704c38d6fd446",
      "line": 324,
      "relation": "association",
      "source": 198,
      "target": 68
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Fetus": true
        },
        "MeSHDisease": {
          "Infection": true
        },
        "Species": {
          "9989": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "In rodents, even infection and systemic inflammation in the fetus during the prenatal or perinatal period can cause long-term cognitive damage, including learning, memory and attention abnormalities, a model that explains why early infection increases the risk of psychosis in young adulthood 38,39.",
      "key": "9bbd2f04d412956ba3673a71a2dd5508",
      "line": 332,
      "relation": "decreases",
      "source": 198,
      "target": 68
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Disease": {
          "Alzheimer's disease": true
        },
        "MeSHDisease": {
          "Inflammation": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "Chronic inflammation is implicated in schizophrenia and other psychiatric disorders 32, and systemic inflammation, as well as acute infections, have been associated with an increased rate of cognitive decline and exacerbation of symptoms in patients with Alzheimer disease (AD) 33.",
      "key": "fa54ac80516814ae647f6895778d98e1",
      "line": 288,
      "relation": "increases",
      "source": 198,
      "target": 187
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Inflammation": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "Chronic low-grade inflammation is also present in people who are obese 34, and this inflammation influences cognitive performance by damaging neuronal circuits and the BBB and by activating pro-inflammatory immune cells 35.",
      "key": "c42004e020529b6784f7529235253c1d",
      "line": 296,
      "relation": "association",
      "source": 198,
      "target": 150
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Inflammation": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "Chronic low-grade inflammation is also present in people who are obese 34, and this inflammation influences cognitive performance by damaging neuronal circuits and the BBB and by activating pro-inflammatory immune cells 35.",
      "key": "cd9ca3d35c77b47df121cab666c1fbb5",
      "line": 298,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 198,
      "target": 36
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Multiple Sclerosis": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "Inflammation in MS, the local effects of which include microglial activation and myelin and neuronal damage, is thought to be primarily mediated by auto reactive T cells.",
      "key": "b9c34629a2e9682e5f365403ef403581",
      "line": 577,
      "object": {
        "modifier": "Degradation"
      },
      "relation": "increases",
      "source": 198,
      "target": 36
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Inflammation": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "Chronic low-grade inflammation is also present in people who are obese 34, and this inflammation influences cognitive performance by damaging neuronal circuits and the BBB and by activating pro-inflammatory immune cells 35.",
      "key": "8a67d0eb764e99ab0fb137c28ee0e9ad",
      "line": 299,
      "relation": "decreases",
      "source": 198,
      "target": 11
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Inflammation": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "The right balance of inflammation is needed for optimal CNS function.",
      "key": "fc36f29671ce735c3698fa5383784dcb",
      "line": 313,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 198,
      "target": 12
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Fetus": true
        },
        "MeSHDisease": {
          "Infection": true
        },
        "Species": {
          "9989": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "In rodents, even infection and systemic inflammation in the fetus during the prenatal or perinatal period can cause long-term cognitive damage, including learning, memory and attention abnormalities, a model that explains why early infection increases the risk of psychosis in young adulthood 38,39.",
      "key": "36619fbdd534c5fdb5b0f5352050b9c3",
      "line": 334,
      "relation": "increases",
      "source": 198,
      "target": 135
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Fetus": true
        },
        "MeSHDisease": {
          "Infection": true
        },
        "Species": {
          "9989": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "In rodents, even infection and systemic inflammation in the fetus during the prenatal or perinatal period can cause long-term cognitive damage, including learning, memory and attention abnormalities, a model that explains why early infection increases the risk of psychosis in young adulthood 38,39.",
      "key": "8a802cc437257ebc0148ad73cf97e80c",
      "line": 336,
      "relation": "decreases",
      "source": 198,
      "target": 52
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Fetus": true
        },
        "MeSHDisease": {
          "Infection": true
        },
        "Species": {
          "9989": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "In rodents, even infection and systemic inflammation in the fetus during the prenatal or perinatal period can cause long-term cognitive damage, including learning, memory and attention abnormalities, a model that explains why early infection increases the risk of psychosis in young adulthood 38,39.",
      "key": "23b03ccaafacea84d9359a8ee182ac7b",
      "line": 338,
      "relation": "decreases",
      "source": 198,
      "target": 194
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Multiple Sclerosis": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "Inflammation in MS, the local effects of which include microglial activation and myelin and neuronal damage, is thought to be primarily mediated by auto reactive T cells.",
      "key": "b38dac4bf26d8a01e90761699493db6a",
      "line": 575,
      "relation": "increases",
      "source": 198,
      "target": 53
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Multiple Sclerosis": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "Inflammation in MS, the local effects of which include microglial activation and myelin and neuronal damage, is thought to be primarily mediated by auto reactive T cells.",
      "key": "1a1c333b826a08f6255c4b766e0496b3",
      "line": 576,
      "object": {
        "modifier": "Degradation"
      },
      "relation": "increases",
      "source": 198,
      "target": 6
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Multiple Sclerosis": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "These observations underline the role of inflammation in relapse activity, as both systemic infection and stress induce a pro-inflammatory status, as discussed in more detail below.",
      "key": "3a8449ee5f379bdcbe30b59e015fc297",
      "line": 597,
      "relation": "increases",
      "source": 198,
      "target": 202
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Inflammation": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "For example, cytokines can have neurotoxic effects by increasing production of reactive oxygen species, reducing monoamine transmission and potentiating glutamatergic transmission.",
      "key": "1326ec6171aa594288a009c58d94793e",
      "line": 272,
      "relation": "increases",
      "source": 34,
      "target": 2
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Inflammation": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "For example, cytokines can have neurotoxic effects by increasing production of reactive oxygen species, reducing monoamine transmission and potentiating glutamatergic transmission.",
      "key": "8c7b406ca59236bef448b156f2320346",
      "line": 273,
      "relation": "decreases",
      "source": 34,
      "target": 54
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Inflammation": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "For example, cytokines can have neurotoxic effects by increasing production of reactive oxygen species, reducing monoamine transmission and potentiating glutamatergic transmission.",
      "key": "7e343ef1628f957155ffb69cf5e594ac",
      "line": 274,
      "relation": "increases",
      "source": 34,
      "target": 66
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Inflammation": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "For example, cytokines can have neurotoxic effects by increasing production of reactive oxygen species, reducing monoamine transmission and potentiating glutamatergic transmission.",
      "key": "4e3352042aab0a7803d3f1dd0ed4741f",
      "line": 275,
      "relation": "increases",
      "source": 2,
      "target": 130
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Inflammation": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "For example, cytokines can have neurotoxic effects by increasing production of reactive oxygen species, reducing monoamine transmission and potentiating glutamatergic transmission.",
      "key": "d1fc070a5d96bfcf576b4725de43fd3a",
      "line": 276,
      "relation": "decreases",
      "source": 54,
      "target": 130
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Inflammation": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "For example, cytokines can have neurotoxic effects by increasing production of reactive oxygen species, reducing monoamine transmission and potentiating glutamatergic transmission.",
      "key": "077ada2fe5e01f830af4fe3ec0dfaee4",
      "line": 277,
      "relation": "increases",
      "source": 66,
      "target": 130
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Inflammation": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "Chronic inflammation is implicated in schizophrenia and other psychiatric disorders 32, and systemic inflammation, as well as acute infections, have been associated with an increased rate of cognitive decline and exacerbation of symptoms in patients with Alzheimer disease (AD) 33.",
      "key": "5b5e49952ebec0e22d583bcef437ff31",
      "line": 283,
      "relation": "increases",
      "source": 151,
      "target": 198
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "Independent of immune pathogenesis, glutamate receptor hypofunction has been proposed as a key factor in the development of schizophrenia 98.",
      "key": "c20c784cf24305c33036997411ae8968",
      "line": 693,
      "relation": "positiveCorrelation",
      "source": 151,
      "target": 118
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "Furthermore, extensive studies of cytokine profiles in disorders such as schizophrenia, depression, suicidal ideation and post-traumatic stress disorder reveal wide-ranging dysregulation of mainly pro-inflammatory markers, in particular IL-6, IL-2 receptor, IL-1β, IL-17 A and C-reactive protein (CRP) 103–107.",
      "key": "6c8d0bd5d7d461a23e47320cb32089be",
      "line": 698,
      "relation": "negativeCorrelation",
      "source": 151,
      "target": 111
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "Furthermore, extensive studies of cytokine profiles in disorders such as schizophrenia, depression, suicidal ideation and post-traumatic stress disorder reveal wide-ranging dysregulation of mainly pro-inflammatory markers, in particular IL-6, IL-2 receptor, IL-1β, IL-17 A and C-reactive protein (CRP) 103–107.",
      "key": "17375bb9af5f9ebd38f89389ed69c7ad",
      "line": 699,
      "relation": "negativeCorrelation",
      "source": 151,
      "target": 109
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "Furthermore, extensive studies of cytokine profiles in disorders such as schizophrenia, depression, suicidal ideation and post-traumatic stress disorder reveal wide-ranging dysregulation of mainly pro-inflammatory markers, in particular IL-6, IL-2 receptor, IL-1β, IL-17 A and C-reactive protein (CRP) 103–107.",
      "key": "38ff6d50e63c3eec2c74d9fafa3d7a0c",
      "line": 700,
      "relation": "negativeCorrelation",
      "source": 151,
      "target": 108
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "Furthermore, extensive studies of cytokine profiles in disorders such as schizophrenia, depression, suicidal ideation and post-traumatic stress disorder reveal wide-ranging dysregulation of mainly pro-inflammatory markers, in particular IL-6, IL-2 receptor, IL-1β, IL-17 A and C-reactive protein (CRP) 103–107.",
      "key": "fc7c2247c3d1db1cad48519a59989530",
      "line": 701,
      "relation": "negativeCorrelation",
      "source": 151,
      "target": 107
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "Furthermore, extensive studies of cytokine profiles in disorders such as schizophrenia, depression, suicidal ideation and post-traumatic stress disorder reveal wide-ranging dysregulation of mainly pro-inflammatory markers, in particular IL-6, IL-2 receptor, IL-1β, IL-17 A and C-reactive protein (CRP) 103–107.",
      "key": "d44f77e0dbf315f65007dee049ea5b74",
      "line": 702,
      "relation": "negativeCorrelation",
      "source": 151,
      "target": 103
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "For example, the MHC-resident complement C4 cluster has been implicated in the risk of schizophrenia 128,129.",
      "key": "211b23c8fa687729bc81356e8f605d23",
      "line": 792,
      "relation": "positiveCorrelation",
      "source": 151,
      "target": 100
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Inflammation": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "Chronic inflammation is implicated in schizophrenia and other psychiatric disorders 32, and systemic inflammation, as well as acute infections, have been associated with an increased rate of cognitive decline and exacerbation of symptoms in patients with Alzheimer disease (AD) 33.",
      "key": "e538ac798513ca52da7095a44ee73625",
      "line": 284,
      "relation": "increases",
      "source": 177,
      "target": 198
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "A well-recognized risk factor for exacerbation in MS and many psychiatric disorders is psychosocial stress.",
      "key": "bcfe97a115b9ff57430c48dd08d45a46",
      "line": 843,
      "relation": "positiveCorrelation",
      "source": 177,
      "target": 186
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Inflammation": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "Chronic low-grade inflammation is also present in people who are obese 34, and this inflammation influences cognitive performance by damaging neuronal circuits and the BBB and by activating pro-inflammatory immune cells 35.",
      "key": "1d35ed3d94ebce154b32adf108ce07c7",
      "line": 296,
      "relation": "association",
      "source": 150,
      "target": 198
    },
    {
      "annotations": {
        "Anatomy": {
          "amygdala": true,
          "brainstem": true,
          "cortex": true,
          "hypothalamus": true
        },
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Hippocampus": true
        },
        "MeSHDisease": {
          "Inflammation": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "These obesity-related mechanisms were initially observed in the hypothalamus, but some evidence suggests that they can also occur in the hippocampus, cortex, brainstem and amygdala 36.",
      "key": "cefa6d5e40313a144e02facc402095c2",
      "line": 306,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 150,
      "target": 36
    },
    {
      "annotations": {
        "Anatomy": {
          "nucleus accumbens": true
        },
        "Confidence": {
          "High": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "In a mouse model of chronic social defeat stress, BBB integrity was altered in the nucleus accumbens owing to downregulation of the tight junction protein claudin 5, thereby allowing influx of IL-6 into the brain parenchyma 153.",
      "key": "5f6e39fdf2e4f2c385e94b2ec7bb8802",
      "line": 859,
      "relation": "decreases",
      "source": 11,
      "subject": {
        "modifier": "Degradation"
      },
      "target": 101
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "Similarly, a viral infection in the mother during the first trimester of pregnancy and bacterial infection during the second trimester of pregnancy were associated with the development of autism spectrum disorder (ASD), a pervasive neurodevelopmental disorder defined by impairments in social skills and stereotypical behaviour, among the children in a large Danish cohort 40.",
      "key": "d64ba6974be27c03587ff5a9098e5bce",
      "line": 355,
      "relation": "isA",
      "source": 133,
      "target": 182
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "Similarly, a viral infection in the mother during the first trimester of pregnancy and bacterial infection during the second trimester of pregnancy were associated with the development of autism spectrum disorder (ASD), a pervasive neurodevelopmental disorder defined by impairments in social skills and stereotypical behaviour, among the children in a large Danish cohort 40.",
      "key": "c88d4f89c13bafa009be07e09b03aa0f",
      "line": 356,
      "relation": "decreases",
      "source": 133,
      "target": 64
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Species": {
          "10116": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "In rodents, the role of maternal immune activation in ASD was confirmed at the transcriptome level, in which immune activation in the mother caused dysregulation in the fetal brain expression of genes involved in developmental processes 120.",
      "key": "182ff911d94d0f22a14056c5ce98bb98",
      "line": 769,
      "relation": "positiveCorrelation",
      "source": 133,
      "target": 80
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "Minocycline also had positive effects as an adjunctive treatment to risperidone in children with ASD 145, although not as a single medication in a small pilot study 146.",
      "key": "0fee53095b96bb06ca0f2b63486ab348",
      "line": 830,
      "relation": "negativeCorrelation",
      "source": 133,
      "target": 96
    },
    {
      "annotations": {
        "Anatomy": {
          "pharynx": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "In children, throat infection with Streptococcus pyogenes has repeatedly been associated with subsequent neuropsychiatric disorders 41.",
      "key": "f5f1eabd6c9fd0330682bdea9a4256ec",
      "line": 363,
      "relation": "increases",
      "source": 22,
      "target": 197
    },
    {
      "annotations": {
        "Anatomy": {
          "pharynx": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "In children, throat infection with Streptococcus pyogenes has repeatedly been associated with subsequent neuropsychiatric disorders 41.",
      "key": "6a57d7017493d1d4748a52517e4d4e10",
      "line": 364,
      "relation": "increases",
      "source": 22,
      "target": 184
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "In particular, these disorders include Sydenham chorea, a movement disorder related to rheumatic fever that occurs in temporal relationship to group A streptococcal infection 42, and conditions encompassed by the umbrella term of paediatric autoimmune neuropsychiatric disorders associated with S. pyogenes (PANDAS) and concomitant with obsessive–compulsive disorder, tic disorder or choreiform motoric hyperactivity 43.",
      "key": "16c03fde712ee26d281a4cea0e2f601c",
      "line": 373,
      "relation": "increases",
      "source": 22,
      "target": 184
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "In particular, these disorders include Sydenham chorea, a movement disorder related to rheumatic fever that occurs in temporal relationship to group A streptococcal infection 42, and conditions encompassed by the umbrella term of paediatric autoimmune neuropsychiatric disorders associated with S. pyogenes (PANDAS) and concomitant with obsessive–compulsive disorder, tic disorder or choreiform motoric hyperactivity 43.",
      "key": "653a855fff4bf40b90ff62e7f5f70032",
      "line": 370,
      "relation": "increases",
      "source": 22,
      "target": 196
    },
    {
      "annotations": {
        "Anatomy": {
          "brain": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "The suspected pathophysiology of PANDAS is cross reactivity of anti-streptococcus A antibodies with brain tissue due to molecular mimicry 44 that initiates an adaptive immune cell response.",
      "key": "49bb44c0d90ccc0f55f2004978f17f72",
      "line": 382,
      "relation": "increases",
      "source": 184,
      "target": 82
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "In particular, these disorders include Sydenham chorea, a movement disorder related to rheumatic fever that occurs in temporal relationship to group A streptococcal infection 42, and conditions encompassed by the umbrella term of paediatric autoimmune neuropsychiatric disorders associated with S. pyogenes (PANDAS) and concomitant with obsessive–compulsive disorder, tic disorder or choreiform motoric hyperactivity 43.",
      "key": "fbfd7914997a66932021682093e4f184",
      "line": 371,
      "relation": "increases",
      "source": 196,
      "target": 180
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "In particular, these disorders include Sydenham chorea, a movement disorder related to rheumatic fever that occurs in temporal relationship to group A streptococcal infection 42, and conditions encompassed by the umbrella term of paediatric autoimmune neuropsychiatric disorders associated with S. pyogenes (PANDAS) and concomitant with obsessive–compulsive disorder, tic disorder or choreiform motoric hyperactivity 43.",
      "key": "da6b915c4346ad88c3a0c45a50ce4d96",
      "line": 372,
      "relation": "association",
      "source": 196,
      "target": 143
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "In particular, these disorders include Sydenham chorea, a movement disorder related to rheumatic fever that occurs in temporal relationship to group A streptococcal infection 42, and conditions encompassed by the umbrella term of paediatric autoimmune neuropsychiatric disorders associated with S. pyogenes (PANDAS) and concomitant with obsessive–compulsive disorder, tic disorder or choreiform motoric hyperactivity 43.",
      "key": "acb51ed632b840474d340d0a926ab16c",
      "line": 372,
      "relation": "association",
      "source": 143,
      "target": 196
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "In particular, these disorders include Sydenham chorea, a movement disorder related to rheumatic fever that occurs in temporal relationship to group A streptococcal infection 42, and conditions encompassed by the umbrella term of paediatric autoimmune neuropsychiatric disorders associated with S. pyogenes (PANDAS) and concomitant with obsessive–compulsive disorder, tic disorder or choreiform motoric hyperactivity 43.",
      "key": "765e30d297497c9543b2149fb6a7bbca",
      "line": 374,
      "relation": "increases",
      "source": 191,
      "target": 183
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "In particular, these disorders include Sydenham chorea, a movement disorder related to rheumatic fever that occurs in temporal relationship to group A streptococcal infection 42, and conditions encompassed by the umbrella term of paediatric autoimmune neuropsychiatric disorders associated with S. pyogenes (PANDAS) and concomitant with obsessive–compulsive disorder, tic disorder or choreiform motoric hyperactivity 43.",
      "key": "fa937f22725cf77d00793094f82ac3c8",
      "line": 375,
      "relation": "increases",
      "source": 191,
      "target": 147
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "In particular, these disorders include Sydenham chorea, a movement disorder related to rheumatic fever that occurs in temporal relationship to group A streptococcal infection 42, and conditions encompassed by the umbrella term of paediatric autoimmune neuropsychiatric disorders associated with S. pyogenes (PANDAS) and concomitant with obsessive–compulsive disorder, tic disorder or choreiform motoric hyperactivity 43.",
      "key": "c5e9fc6b2770cf579343df52c94e8761",
      "line": 376,
      "relation": "increases",
      "source": 191,
      "target": 179
    },
    {
      "annotations": {
        "Anatomy": {
          "brain": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "The suspected pathophysiology of PANDAS is cross reactivity of anti-streptococcus A antibodies with brain tissue due to molecular mimicry 44 that initiates an adaptive immune cell response.",
      "key": "490e509b227643861d1457f128d3e0a3",
      "line": 383,
      "relation": "increases",
      "source": 82,
      "target": 40
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "In addition to molecular mimicry that triggers autoimmune reactions, a possible mechanism is stress-induced potentiation of microglial inflammasome activation, which causes an increase in pro-inflammatory mediators 52,53.",
      "key": "ef361930087b858a83ece35368086071",
      "line": 428,
      "relation": "increases",
      "source": 82,
      "target": 170
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "Severe infections, such as herpes simplex virus (HSV) encephalitis at any time in the lifespan, have been associated with long-term impairment of memory and brain atrophy 47.",
      "key": "c72e18bb1d46f90ad3efabdbe9583b73",
      "line": 389,
      "relation": "decreases",
      "source": 157,
      "target": 52
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "Severe infections, such as herpes simplex virus (HSV) encephalitis at any time in the lifespan, have been associated with long-term impairment of memory and brain atrophy 47.",
      "key": "559e719ae75c1225c74e9f8e8fcb4b91",
      "line": 390,
      "relation": "increases",
      "source": 157,
      "target": 154
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "A compelling example of the overlap between psychiatric and neurological pathologies is the occurrence of psychosis as a result of autoantibodies against neuropil, which can develop spontaneously in neoplastic diseases or after viral infections, particularly HSV encephalitis 86.",
      "key": "10aae190f34324460aec2e258ca48ddb",
      "line": 639,
      "relation": "increases",
      "source": 157,
      "target": 91
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "For example, latent cytomegalovirus (CMV) infection leads to accumulation of functionally exhausted effector T cells while the naive T cell pool is diminished 48.",
      "key": "c63c8921d0b24c8394bb152dd65d6b11",
      "line": 395,
      "relation": "increases",
      "source": 172,
      "target": 152
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "For example, latent cytomegalovirus (CMV) infection leads to accumulation of functionally exhausted effector T cells while the naive T cell pool is diminished 48.",
      "key": "e22fc0105c11654ad32685f5ce22e82e",
      "line": 396,
      "relation": "increases",
      "source": 172,
      "target": 160
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "In the prospective Northern Manhattan Study, a high infectious burden (assessed with serological markers for Chlamydia pneumoniae, Helicobacter pylori, CMV, HSV-1 and HSV-2) was associated with cognitive decline independently of cardiovascular risk among a cohort of 1,625 patients 49.",
      "key": "82ec928691a2432c22e36e7c6b272390",
      "line": 403,
      "relation": "decreases",
      "source": 172,
      "target": 68
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Bipolar Disorder": true,
          "Schizophrenia": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "Evidence suggests that among patients with schizophrenia or bipolar disorder, infections with Toxoplasma gondii, HSV and CMV affect the cognitive dysfunction already present in these disorders, in particular working memory 50.",
      "key": "edb58d64970bf14c615d153fc3993f22",
      "line": 414,
      "relation": "decreases",
      "source": 172,
      "target": 68
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "In the prospective Northern Manhattan Study, a high infectious burden (assessed with serological markers for Chlamydia pneumoniae, Helicobacter pylori, CMV, HSV-1 and HSV-2) was associated with cognitive decline independently of cardiovascular risk among a cohort of 1,625 patients 49.",
      "key": "523949eb343df4ff221c9c84e8fa2eda",
      "line": 402,
      "relation": "decreases",
      "source": 156,
      "target": 68
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "In the prospective Northern Manhattan Study, a high infectious burden (assessed with serological markers for Chlamydia pneumoniae, Helicobacter pylori, CMV, HSV-1 and HSV-2) was associated with cognitive decline independently of cardiovascular risk among a cohort of 1,625 patients 49.",
      "key": "550821f3cb0311b6ece7b1a5d802730e",
      "line": 404,
      "relation": "decreases",
      "source": 16,
      "target": 68
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Bipolar Disorder": true,
          "Schizophrenia": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "Evidence suggests that among patients with schizophrenia or bipolar disorder, infections with Toxoplasma gondii, HSV and CMV affect the cognitive dysfunction already present in these disorders, in particular working memory 50.",
      "key": "bb9fdc5cac0d1914648f67538da48092",
      "line": 412,
      "relation": "decreases",
      "source": 16,
      "target": 68
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "On a population level, data from a Swedish cohort suggest that reactivation of HSV-1, indicated by high serum levels of anti-HSV immunoglobulin M (IgM) antibodies, increases the risk of developing AD 55.",
      "key": "31eeb1d746e18271829f5e10906fa8ff",
      "line": 464,
      "relation": "positiveCorrelation",
      "source": 16,
      "target": 131
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "In vitro experiments have shown that HSV-1 induces increases in intracellular amyloid-β (Aβ) levels and tau phosphorylation, both of which are markers of AD 56.",
      "key": "290d0f9027f43bea00cf921f4eb331f7",
      "line": 470,
      "object": {
        "location": {
          "name": "intracellular",
          "namespace": "GO"
        }
      },
      "relation": "increases",
      "source": 16,
      "target": 0
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "In vitro experiments have shown that HSV-1 induces increases in intracellular amyloid-β (Aβ) levels and tau phosphorylation, both of which are markers of AD 56.",
      "key": "5dfeff20dc1658e43d686ded258d5379",
      "line": 471,
      "relation": "increases",
      "source": 16,
      "target": 113
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "In addition, HSV-1 DNA has been found in amyloid plaques in patients with AD, further underlining a link between the virus and pathological aggregations 57.",
      "key": "1261438616e624707b2ea818a5435fa5",
      "line": 478,
      "relation": "association",
      "source": 16,
      "target": 185
    },
    {
      "annotations": {
        "Cell": {
          "neuron": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "For example, HSV-1 proteins debilitate neuronal autophagy and, consequently, antigen presentation 58.",
      "key": "68a7ed031dd6e2cd5511480b431a77f7",
      "line": 484,
      "relation": "decreases",
      "source": 16,
      "target": 67
    },
    {
      "annotations": {
        "Cell": {
          "neuron": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "For example, HSV-1 proteins debilitate neuronal autophagy and, consequently, antigen presentation 58.",
      "key": "795b84f6fa6ad54fbd2333485932bf16",
      "line": 485,
      "relation": "decreases",
      "source": 16,
      "target": 76
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "In mice, recurrent asymptomatic activation of HSV-1 leads to upregulation of markers of neuroinflammation (for example, Toll-like receptor-4, IFNα and IFNβ) and early neurodegeneration 59.",
      "key": "6e842450b8ed0920b9ece50e066ea646",
      "line": 492,
      "relation": "increases",
      "source": 16,
      "target": 114
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "In mice, recurrent asymptomatic activation of HSV-1 leads to upregulation of markers of neuroinflammation (for example, Toll-like receptor-4, IFNα and IFNβ) and early neurodegeneration 59.",
      "key": "fe80a4a0ae786bf7c6e0f78172cac190",
      "line": 493,
      "relation": "increases",
      "source": 16,
      "target": 105
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "In mice, recurrent asymptomatic activation of HSV-1 leads to upregulation of markers of neuroinflammation (for example, Toll-like receptor-4, IFNα and IFNβ) and early neurodegeneration 59.",
      "key": "ac66543b1c9f022bf408bff41c1d2257",
      "line": 494,
      "relation": "increases",
      "source": 16,
      "target": 106
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "In the prospective Northern Manhattan Study, a high infectious burden (assessed with serological markers for Chlamydia pneumoniae, Helicobacter pylori, CMV, HSV-1 and HSV-2) was associated with cognitive decline independently of cardiovascular risk among a cohort of 1,625 patients 49.",
      "key": "2350ec9493cb1658193e0fe9e5dc523a",
      "line": 405,
      "relation": "decreases",
      "source": 17,
      "target": 68
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Bipolar Disorder": true,
          "Schizophrenia": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "Evidence suggests that among patients with schizophrenia or bipolar disorder, infections with Toxoplasma gondii, HSV and CMV affect the cognitive dysfunction already present in these disorders, in particular working memory 50.",
      "key": "598d621a4a870a1cc2604073eca33986",
      "line": 413,
      "relation": "decreases",
      "source": 17,
      "target": 68
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Bipolar Disorder": true,
          "Schizophrenia": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "Evidence suggests that among patients with schizophrenia or bipolar disorder, infections with Toxoplasma gondii, HSV and CMV affect the cognitive dysfunction already present in these disorders, in particular working memory 50.",
      "key": "670acafcd7779e78d57353f54c3bae9b",
      "line": 411,
      "relation": "decreases",
      "source": 203,
      "target": 68
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "Another example of the intricate relationship between cognition and chronic infection is HIV-associated neurocognitive disorder, which emerges in patients with HIV infection despite highly active antiretroviral therapy 51.",
      "key": "38d8b4deae286bef805264f2ef874c9a",
      "line": 420,
      "relation": "increases",
      "source": 173,
      "target": 181
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "HIV Infections": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "Another example of the intricate relationship between cognition and chronic infection is HIV-associated neurocognitive disorder, which emerges in patients with HIV infection despite highly active antiretroviral therapy 51.",
      "key": "ef41b77a8e58468f91218d43df1b7bfe",
      "line": 422,
      "relation": "causesNoChange",
      "source": 169,
      "target": 181
    },
    {
      "annotations": {
        "Cell": {
          "microglial cell": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "In addition to molecular mimicry that triggers autoimmune reactions, a possible mechanism is stress-induced potentiation of microglial inflammasome activation, which causes an increase in pro-inflammatory mediators 52,53.",
      "key": "6ff8fd23ebd7e11bb4d808458f348c23",
      "line": 430,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 63,
      "target": 90
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Multiple Sclerosis": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "Relapses in patients with MS are influenced by stressful life events and by infections: a systematic meta-analysis has shown that upper respiratory tract infections have the most pronounced effect on relapse rates 74.",
      "key": "d70499c1d170bfdb59aa03f02f1f1ed8",
      "line": 590,
      "relation": "increases",
      "source": 63,
      "target": 202
    },
    {
      "annotations": {
        "Cell": {
          "microglial cell": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "In addition to molecular mimicry that triggers autoimmune reactions, a possible mechanism is stress-induced potentiation of microglial inflammasome activation, which causes an increase in pro-inflammatory mediators 52,53.",
      "key": "308a59c155460c35b8ce0f711d4fc46d",
      "line": 431,
      "relation": "increases",
      "source": 90,
      "subject": {
        "modifier": "Activity"
      },
      "target": 18
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "In this way, both innate (microglial activation with subsequent phagocytosis or cytokine production) and adaptive immune responses (antigen-specific responsiveness and production of antibodies) contribute to pathology.",
      "key": "08bde2120b1a4ebdf51d05752637e2aa",
      "line": 440,
      "relation": "increases",
      "source": 47,
      "target": 79
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "In this way, both innate (microglial activation with subsequent phagocytosis or cytokine production) and adaptive immune responses (antigen-specific responsiveness and production of antibodies) contribute to pathology.",
      "key": "b8b66ce1822003fd1180c55644f25ee3",
      "line": 441,
      "relation": "increases",
      "source": 79,
      "target": 200
    },
    {
      "annotations": {
        "Anatomy": {
          "central nervous system": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "Changes in the innate CNS immune compartment have also been associated with psychiatric disorders.",
      "key": "9ad54af50f0474dd980bd8193263ec69",
      "line": 718,
      "relation": "association",
      "source": 79,
      "target": 199
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "In this way, both innate (microglial activation with subsequent phagocytosis or cytokine production) and adaptive immune responses (antigen-specific responsiveness and production of antibodies) contribute to pathology.",
      "key": "96af02c81b25d89a00930aef77281186",
      "line": 442,
      "relation": "increases",
      "source": 75,
      "target": 74
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "Cytokine signalling is not the only aspect of maternal immunity that affects the developing fetal brain — B cell-mediated immune responses and production of antibodies can also have effects.",
      "key": "1c1bbb010d3dd0d6f98d70a2c9039053",
      "line": 777,
      "relation": "association",
      "source": 75,
      "target": 49
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "In this way, both innate (microglial activation with subsequent phagocytosis or cytokine production) and adaptive immune responses (antigen-specific responsiveness and production of antibodies) contribute to pathology.",
      "key": "9c56218bb31a9c58d603a253a581f95a",
      "line": 443,
      "relation": "increases",
      "source": 126,
      "subject": {
        "modifier": "Activity"
      },
      "target": 74
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "In addition, infectious agents might act via epigenetic pathways to modulate the innate immune cell repertoire, thereby influencing the risk profile for neurodegenerative disorders 54.",
      "key": "d202eb0d1de976a0d7e8b5ed9055d8cd",
      "line": 449,
      "relation": "increases",
      "source": 71,
      "target": 60
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "In addition, infectious agents might act via epigenetic pathways to modulate the innate immune cell repertoire, thereby influencing the risk profile for neurodegenerative disorders 54.",
      "key": "9323327cfc6de7395378b4fb1447c3f1",
      "line": 451,
      "relation": "positiveCorrelation",
      "source": 71,
      "target": 138
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "In addition to the cumulative effect of infectious burden, pathogens contribute directly to neurodegeneration, and therefore cognitive decline, in elderly people.",
      "key": "e168e7b34c4e0ee8e26aebffb68648f1",
      "line": 457,
      "relation": "increases",
      "source": 71,
      "target": 138
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "In addition to the cumulative effect of infectious burden, pathogens contribute directly to neurodegeneration, and therefore cognitive decline, in elderly people.",
      "key": "fdb3932a09042be1065f42f3a04e6d73",
      "line": 458,
      "relation": "decreases",
      "source": 71,
      "target": 68
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "In addition, infectious agents might act via epigenetic pathways to modulate the innate immune cell repertoire, thereby influencing the risk profile for neurodegenerative disorders 54.",
      "key": "487c632642cac8adfcc5aa167d37943c",
      "line": 450,
      "relation": "regulates",
      "source": 60,
      "target": 79
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "In addition, infectious agents might act via epigenetic pathways to modulate the innate immune cell repertoire, thereby influencing the risk profile for neurodegenerative disorders 54.",
      "key": "a774f17cb0555854ca460ab2584b63ba",
      "line": 451,
      "relation": "positiveCorrelation",
      "source": 138,
      "target": 71
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "On a population level, data from a Swedish cohort suggest that reactivation of HSV-1, indicated by high serum levels of anti-HSV immunoglobulin M (IgM) antibodies, increases the risk of developing AD 55.",
      "key": "ec42f68b39bcc982b6c6c0521a93a897",
      "line": 464,
      "relation": "positiveCorrelation",
      "source": 131,
      "target": 16
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "In vitro experiments have shown that HSV-1 induces increases in intracellular amyloid-β (Aβ) levels and tau phosphorylation, both of which are markers of AD 56.",
      "key": "a73941ff47490b44e637b1e6cb55b11e",
      "line": 472,
      "relation": "biomarkerFor",
      "source": 0,
      "subject": {
        "location": {
          "name": "intracellular",
          "namespace": "GO"
        }
      },
      "target": 131
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "In addition, extracellular deposits of Aβ activate resting microglia and trigger them to attack neurons via various pathways, such as NADPH oxidase activation, inducible nitric oxide synthase expression and phagocytosis 60.",
      "key": "b08297526dd3a0be6052328de387a6e2",
      "line": 505,
      "relation": "increases",
      "source": 0,
      "subject": {
        "location": {
          "name": "extracellular matrix",
          "namespace": "GO"
        }
      },
      "target": 53
    },
    {
      "key": "064f60bbd4e86ec0d71e89e733af2e71",
      "relation": "hasVariant",
      "source": 112,
      "target": 113
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "In vitro experiments have shown that HSV-1 induces increases in intracellular amyloid-β (Aβ) levels and tau phosphorylation, both of which are markers of AD 56.",
      "key": "d398d05ab21d537a34e8d792a6d9bc0d",
      "line": 473,
      "relation": "biomarkerFor",
      "source": 112,
      "target": 131
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "In addition, HSV-1 DNA has been found in amyloid plaques in patients with AD, further underlining a link between the virus and pathological aggregations 57.",
      "key": "813f83883626e75179b1ca54cacf8f7f",
      "line": 478,
      "relation": "association",
      "source": 185,
      "target": 16
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "Autoimmune responses can be antibody driven or cell driven and, depending on the autoantigen involved, can involve antigen presentation by major histocompatibility complex (MHC) class II.",
      "key": "e6f75975e66928723c778233bad18561",
      "line": 523,
      "relation": "increases",
      "source": 76,
      "target": 163
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "In mice, recurrent asymptomatic activation of HSV-1 leads to upregulation of markers of neuroinflammation (for example, Toll-like receptor-4, IFNα and IFNβ) and early neurodegeneration 59.",
      "key": "c9950cd97f87f67702d2da4fa8df91e0",
      "line": 495,
      "relation": "biomarkerFor",
      "source": 114,
      "target": 129
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "In mice, recurrent asymptomatic activation of HSV-1 leads to upregulation of markers of neuroinflammation (for example, Toll-like receptor-4, IFNα and IFNβ) and early neurodegeneration 59.",
      "key": "ce4912818408cb72c25847e812e970f4",
      "line": 498,
      "relation": "biomarkerFor",
      "source": 114,
      "target": 128
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "In mice, recurrent asymptomatic activation of HSV-1 leads to upregulation of markers of neuroinflammation (for example, Toll-like receptor-4, IFNα and IFNβ) and early neurodegeneration 59.",
      "key": "391ce2436c6346c7653716f6fe8d2d9c",
      "line": 496,
      "relation": "biomarkerFor",
      "source": 105,
      "target": 129
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "In mice, recurrent asymptomatic activation of HSV-1 leads to upregulation of markers of neuroinflammation (for example, Toll-like receptor-4, IFNα and IFNβ) and early neurodegeneration 59.",
      "key": "bfbc400b9ad01d9a78e45891489e5ebb",
      "line": 499,
      "relation": "biomarkerFor",
      "source": 105,
      "target": 128
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Multiple Sclerosis": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "These findings underline the fact that active neuroinflammation detectable with gadolinium enhancement affects cognitive function and might cause detrimental effects on neuronal networks and connectivity.",
      "key": "59569539d09cbd5575283fa885876428",
      "line": 631,
      "relation": "decreases",
      "source": 129,
      "target": 68
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Multiple Sclerosis": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "These findings underline the fact that active neuroinflammation detectable with gadolinium enhancement affects cognitive function and might cause detrimental effects on neuronal networks and connectivity.",
      "key": "1d2f57e4cdd1e88279a85b8625b3d6d6",
      "line": 632,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 129,
      "target": 36
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "Nonspecific inflammatory processes underlie the low-grade inflammation described above, but neuroinflammation can also be driven by autoimmunity",
      "key": "76658849adb124a87e61d0b1fa1e47fa",
      "line": 516,
      "relation": "increases",
      "source": 163,
      "target": 129
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Multiple Sclerosis": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "Inflammation in MS, the local effects of which include microglial activation and myelin and neuronal damage, is thought to be primarily mediated by auto reactive T cells.",
      "key": "8e86a46cfbfbbdde307f1d0d3dfea651",
      "line": 578,
      "relation": "increases",
      "source": 163,
      "target": 198
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Encephalitis": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "Patients with this condition often present with anxiety, sleep disorders, mania, paranoia, memory impairment and disintegration of language, followed by a phase in which agitation and catatonia alternate, accompanied by abnormal movements and autonomic instability 90.",
      "key": "08279c6dd46b0ea92d6e72216ee95ba8",
      "line": 668,
      "relation": "increases",
      "source": 163,
      "target": 132
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Encephalitis": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "Patients with this condition often present with anxiety, sleep disorders, mania, paranoia, memory impairment and disintegration of language, followed by a phase in which agitation and catatonia alternate, accompanied by abnormal movements and autonomic instability 90.",
      "key": "67ed2be58b0cae879ff7828e8f8cf701",
      "line": 669,
      "relation": "increases",
      "source": 163,
      "target": 145
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Encephalitis": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "Patients with this condition often present with anxiety, sleep disorders, mania, paranoia, memory impairment and disintegration of language, followed by a phase in which agitation and catatonia alternate, accompanied by abnormal movements and autonomic instability 90.",
      "key": "47c03ad4d8bb7729b34fc09d3508dd41",
      "line": 670,
      "relation": "increases",
      "source": 163,
      "target": 166
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Encephalitis": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "Patients with this condition often present with anxiety, sleep disorders, mania, paranoia, memory impairment and disintegration of language, followed by a phase in which agitation and catatonia alternate, accompanied by abnormal movements and autonomic instability 90.",
      "key": "c7a434e31699600b2278c6a503fceca0",
      "line": 671,
      "relation": "increases",
      "source": 163,
      "target": 167
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Encephalitis": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "Patients with this condition often present with anxiety, sleep disorders, mania, paranoia, memory impairment and disintegration of language, followed by a phase in which agitation and catatonia alternate, accompanied by abnormal movements and autonomic instability 90.",
      "key": "b5fb95ed67194f0411dc51e03f79d59e",
      "line": 672,
      "relation": "increases",
      "source": 163,
      "target": 158
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Encephalitis": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "Patients with this condition often present with anxiety, sleep disorders, mania, paranoia, memory impairment and disintegration of language, followed by a phase in which agitation and catatonia alternate, accompanied by abnormal movements and autonomic instability 90.",
      "key": "d14396963319a4093befe01bc4ea06bf",
      "line": 673,
      "relation": "increases",
      "source": 163,
      "target": 176
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Encephalitis": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "Patients with this condition often present with anxiety, sleep disorders, mania, paranoia, memory impairment and disintegration of language, followed by a phase in which agitation and catatonia alternate, accompanied by abnormal movements and autonomic instability 90.",
      "key": "0a526fa0bf2389c4a7289264a8cf589e",
      "line": 674,
      "relation": "increases",
      "source": 163,
      "target": 161
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Encephalitis": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "Patients with this condition often present with anxiety, sleep disorders, mania, paranoia, memory impairment and disintegration of language, followed by a phase in which agitation and catatonia alternate, accompanied by abnormal movements and autonomic instability 90.",
      "key": "db94336a0c28cb448a6a56f06ebd17dd",
      "line": 675,
      "relation": "increases",
      "source": 163,
      "target": 195
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Encephalitis": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "Patients with this condition often present with anxiety, sleep disorders, mania, paranoia, memory impairment and disintegration of language, followed by a phase in which agitation and catatonia alternate, accompanied by abnormal movements and autonomic instability 90.",
      "key": "bedb26a939122f3424a4af9f2a20b708",
      "line": 676,
      "relation": "increases",
      "source": 163,
      "target": 153
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "Autoimmune responses can be antibody driven or cell driven and, depending on the autoantigen involved, can involve antigen presentation by major histocompatibility complex (MHC) class II.",
      "key": "1cf295f5d0667c669494f3c9a12cd702",
      "line": 521,
      "relation": "increases",
      "source": 73,
      "target": 163
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Multiple Sclerosis": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "A specific autoantigen has not yet been identified in MS, but autoreactive T cells are widely assumed to target proteins of the myelin sheath, causing demyelination and, thereby, white matter damage.",
      "key": "0f4ab9dcf49b2c58a14c29fc6808dc8b",
      "line": 602,
      "relation": "increases",
      "source": 73,
      "target": 155
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "Autoimmune responses can be antibody driven or cell driven and, depending on the autoantigen involved, can involve antigen presentation by major histocompatibility complex (MHC) class II.",
      "key": "1fe279d02793cd9f9ed4e39c0120fc22",
      "line": 524,
      "relation": "increases",
      "source": 87,
      "target": 163
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "These conditions include neuro myelitis optica and potentially disabling, or sometimes life-threatening, autoimmune encephalomyelitis.",
      "key": "35c8683505aeeda57921108ae705f620",
      "line": 530,
      "relation": "isA",
      "source": 139,
      "target": 134
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "These conditions include neuro myelitis optica and potentially disabling, or sometimes life-threatening, autoimmune encephalomyelitis.",
      "key": "0c0aba26a251c6c2704f2796c5bbb368",
      "line": 531,
      "relation": "isA",
      "source": 149,
      "target": 134
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Multiple Sclerosis": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "MS is the  classical and most common chronic autoimmune encephalomyelitis; this disease leads to demyelination and progressive neurodegeneration.",
      "key": "f44ffde7e9dd480792cae130ab0fcad9",
      "line": 538,
      "relation": "isA",
      "source": 137,
      "target": 149
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Multiple Sclerosis": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "MS is the  classical and most common chronic autoimmune encephalomyelitis; this disease leads to demyelination and progressive neurodegeneration.",
      "key": "6dbf9fcbaf7f9b312ce1743f1894e535",
      "line": 539,
      "relation": "isA",
      "source": 137,
      "target": 170
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Multiple Sclerosis": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "MS is the  classical and most common chronic autoimmune encephalomyelitis; this disease leads to demyelination and progressive neurodegeneration.",
      "key": "04d5e7c8f3938ceb395b7d2c4e349af2",
      "line": 540,
      "relation": "increases",
      "source": 137,
      "target": 155
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Multiple Sclerosis": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "MS is the  classical and most common chronic autoimmune encephalomyelitis; this disease leads to demyelination and progressive neurodegeneration.",
      "key": "ec9056073a96c1e46c3a520d131e25a4",
      "line": 541,
      "relation": "increases",
      "source": 137,
      "target": 128
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Multiple Sclerosis": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "Although these physical deficits are the most obvious consequences, an increasing body of evidence illustrates that cognitive deficits are abundant and extensive in MS 62.",
      "key": "115b04f50f0ae564c7259c7e7c4cede8",
      "line": 552,
      "relation": "decreases",
      "source": 137,
      "target": 68
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Multiple Sclerosis": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "Notably, cognitive impairment at the time of MS diagnosis predicts disability progression, transition to secondary progressive MS and cortical thinning 66.",
      "key": "2b4a523c8155292990079380140ec783",
      "line": 568,
      "relation": "decreases",
      "source": 137,
      "target": 68
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Multiple Sclerosis": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "The most common cognitive deficits, which occur in 40–60% of patients with MS, are reduced processing speed and impaired memory and/or executive function, and these symptoms can improve to some extent with immunomodulatory treatment 64.",
      "key": "9d97f68ec17ee9db4ee9ffeed76d72d0",
      "line": 563,
      "relation": "decreases",
      "source": 137,
      "target": 52
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Multiple Sclerosis": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "Notably, cognitive impairment at the time of MS diagnosis predicts disability progression, transition to secondary progressive MS and cortical thinning 66.",
      "key": "4922eb0faf8e0056e5b6a6aa544cec9b",
      "line": 569,
      "relation": "increases",
      "source": 137,
      "target": 144
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Multiple Sclerosis": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "Notably, cognitive impairment at the time of MS diagnosis predicts disability progression, transition to secondary progressive MS and cortical thinning 66.",
      "key": "ebf3ce3c5d0f3fe24a61a798f0b0240d",
      "line": 570,
      "object": {
        "modifier": "Degradation"
      },
      "relation": "increases",
      "source": 137,
      "target": 13
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Multiple Sclerosis": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "Pro-inflammatory TH17 cells are thought to migrate into the CNS and subsequently increase BBB permeability, enabling invasion of other immune cells 71 (Fig. 1b). Other important players include regulatory T cells, which are functionally impaired in people with MS 72, and B cells, the role of which is highlighted by the effects of B cell-depleting therapies 73.",
      "key": "8655a6559083a7392ff123e4893c677b",
      "line": 584,
      "relation": "decreases",
      "source": 137,
      "target": 26
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Multiple Sclerosis": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "Pro-inflammatory TH17 cells are thought to migrate into the CNS and subsequently increase BBB permeability, enabling invasion of other immune cells 71 (Fig. 1b). Other important players include regulatory T cells, which are functionally impaired in people with MS 72, and B cells, the role of which is highlighted by the effects of B cell-depleting therapies 73.",
      "key": "27b4c239e0f4c19a0bd86f2f6578157d",
      "line": 585,
      "relation": "decreases",
      "source": 137,
      "target": 10
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Multiple Sclerosis": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "Grey matter damage, measured as the cortical lesion load or cortical thinning, is a key predictor of progressive disease and cognitive decline 79.",
      "key": "3c2202ff92f1de243bd7afa294058181",
      "line": 624,
      "object": {
        "modifier": "Degradation"
      },
      "relation": "increases",
      "source": 137,
      "target": 15
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "A well-recognized risk factor for exacerbation in MS and many psychiatric disorders is psychosocial stress.",
      "key": "bd68f9f346e38fe4c3788602dde0d385",
      "line": 844,
      "relation": "positiveCorrelation",
      "source": 137,
      "target": 186
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Multiple Sclerosis": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "A specific autoantigen has not yet been identified in MS, but autoreactive T cells are widely assumed to target proteins of the myelin sheath, causing demyelination and, thereby, white matter damage.",
      "key": "3c36cddb041c1dee26c32e05b82f0adf",
      "line": 604,
      "object": {
        "modifier": "Degradation"
      },
      "relation": "increases",
      "source": 155,
      "target": 30
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Multiple Sclerosis": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "Demyelination deprives neurons of protective factors and has been described to decrease axonal transport and synaptic density in demyelinated hippocampi from post-mortem MS brains 75.",
      "key": "ce5b5c547e7b525a9fde81ce6870c40f",
      "line": 609,
      "relation": "decreases",
      "source": 155,
      "target": 84
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Multiple Sclerosis": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "Demyelination deprives neurons of protective factors and has been described to decrease axonal transport and synaptic density in demyelinated hippocampi from post-mortem MS brains 75.",
      "key": "700f862a97d96950d307cf10e5b15553",
      "line": 610,
      "relation": "decreases",
      "source": 155,
      "target": 42
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Hippocampus": true
        },
        "MeSHDisease": {
          "Multiple Sclerosis": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "Demyelination deprives neurons of protective factors and has been described to decrease axonal transport and synaptic density in demyelinated hippocampi from post-mortem MS brains 75.",
      "key": "705621ff291a796ce87fc1d9b19edeb7",
      "line": 612,
      "relation": "decreases",
      "source": 155,
      "target": 7
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Multiple Sclerosis": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "In early MS, most patients experience transient physical deficits, such as optic neuritis, hemiparesis or sensory disturbances, in a relapsing–remitting presentation.",
      "key": "c08afbcdaeaa569f6747715c33c2c302",
      "line": 546,
      "relation": "increases",
      "source": 142,
      "target": 140
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Multiple Sclerosis": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "In early MS, most patients experience transient physical deficits, such as optic neuritis, hemiparesis or sensory disturbances, in a relapsing–remitting presentation.",
      "key": "934f3c0898bde285ad450d6a7e0fcb5f",
      "line": 547,
      "relation": "increases",
      "source": 142,
      "target": 165
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Multiple Sclerosis": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "Patients with MS can experience neuropsychological symptoms, such as mild cognitive alterations or depression, related not only to relapses but also to phases of remission 63.",
      "key": "e8aa88d9da41017b788917e2ce935280",
      "line": 557,
      "relation": "decreases",
      "source": 142,
      "target": 68
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Multiple Sclerosis": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "Patients with MS can experience neuropsychological symptoms, such as mild cognitive alterations or depression, related not only to relapses but also to phases of remission 63.",
      "key": "143a1b51b8193db7b8da504d236c1381",
      "line": 558,
      "relation": "increases",
      "source": 142,
      "target": 136
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Multiple Sclerosis": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "Pro-inflammatory TH17 cells are thought to migrate into the CNS and subsequently increase BBB permeability, enabling invasion of other immune cells 71 (Fig. 1b). Other important players include regulatory T cells, which are functionally impaired in people with MS 72, and B cells, the role of which is highlighted by the effects of B cell-depleting therapies 73.",
      "key": "563688ea9c43827e5f19d861c64ff444",
      "line": 583,
      "relation": "increases",
      "source": 27,
      "subject": {
        "location": {
          "name": "Central Nervous System",
          "namespace": "MESH"
        }
      },
      "target": 78
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "In mice, autism-like behaviour in offspring requires the presence of maternal RORgammat-positive TH17 cells and IL-17a downstream of IL-6 (reF.115).",
      "key": "07dedc9a706d1ebcc4e05a0731e0094a",
      "line": 752,
      "relation": "increases",
      "source": 27,
      "target": 162
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Multiple Sclerosis": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "Relapses in patients with MS are influenced by stressful life events and by infections: a systematic meta-analysis has shown that upper respiratory tract infections have the most pronounced effect on relapse rates 74.",
      "key": "9ff64db81458a52412e44059be20608f",
      "line": 592,
      "relation": "increases",
      "source": 159,
      "target": 202
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Multiple Sclerosis": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "A specific autoantigen has not yet been identified in MS, but autoreactive T cells are widely assumed to target proteins of the myelin sheath, causing demyelination and, thereby, white matter damage.",
      "key": "ecfb34e21740f2c74cdc75da1862dc9b",
      "line": 603,
      "relation": "increases",
      "source": 25,
      "target": 155
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Neuropsychiatry": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "The presence of these antibodies is diagnostically useful but considered to be an epiphenomenon, as cytotoxic T cells are responsible for neuronal damage that is associated with neuropsychiatric symptoms 87.",
      "key": "b8ce859cdb83f65ae50fd478c5c5a82a",
      "line": 646,
      "object": {
        "modifier": "Degradation"
      },
      "relation": "increases",
      "source": 25,
      "target": 36
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Multiple Sclerosis": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "However, direct recognition of neurons by pathogenic T cells has also been proposed 76,77, and neuronal loss could occur as a result of Wallerian degene ration and mitochondrial dysfunction 78.",
      "key": "60551034cff888c05a6483ca5d521c91",
      "line": 618,
      "object": {
        "modifier": "Degradation"
      },
      "relation": "increases",
      "source": 193,
      "target": 36
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Multiple Sclerosis": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "However, direct recognition of neurons by pathogenic T cells has also been proposed 76,77, and neuronal loss could occur as a result of Wallerian degene ration and mitochondrial dysfunction 78.",
      "key": "3a965b5b6a9d575d42c16a44b64aced2",
      "line": 619,
      "object": {
        "modifier": "Degradation"
      },
      "relation": "increases",
      "source": 127,
      "target": 36
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Multiple Sclerosis": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "Grey matter damage, measured as the cortical lesion load or cortical thinning, is a key predictor of progressive disease and cognitive decline 79.",
      "key": "46e3d4a986b515285504a9155d045d7e",
      "line": 625,
      "relation": "decreases",
      "source": 15,
      "subject": {
        "modifier": "Degradation"
      },
      "target": 68
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Multiple Sclerosis": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "Grey matter damage, measured as the cortical lesion load or cortical thinning, is a key predictor of progressive disease and cognitive decline 79.",
      "key": "88bcdaeeb5554e58346620c4ec2154d6",
      "line": 626,
      "object": {
        "modifier": "Degradation"
      },
      "relation": "increases",
      "source": 15,
      "subject": {
        "modifier": "Degradation"
      },
      "target": 13
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "A compelling example of the overlap between psychiatric and neurological pathologies is the occurrence of psychosis as a result of autoantibodies against neuropil, which can develop spontaneously in neoplastic diseases or after viral infections, particularly HSV encephalitis 86.",
      "key": "927f20adcdbf1fb451e23083852eb5ce",
      "line": 640,
      "relation": "increases",
      "source": 91,
      "target": 168
    },
    {
      "key": "8e9a6f1776fe84889041221b07dca3a8",
      "relation": "partOf",
      "source": 31,
      "target": 91
    },
    {
      "key": "fddd77e71f78075ba02bfb764e8d45e9",
      "relation": "partOf",
      "source": 31,
      "target": 92
    },
    {
      "key": "39a1456cd29c9a07e794333cd88ec0bc",
      "relation": "partOf",
      "source": 31,
      "target": 93
    },
    {
      "key": "b443a2bded4858da544a840d3c0d78f8",
      "relation": "partOf",
      "source": 31,
      "target": 94
    },
    {
      "key": "7def409ba2b6fe841f61c2c77cd85914",
      "relation": "partOf",
      "source": 37,
      "target": 91
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "One example of such an antibody is the autoantibody against the GABAA receptor, a postsynaptic chloride channel that mediates fast inhibitory neurotransmission in the mammalian brain; this autoantibody causes encephalitis with therapy-resistant epileptic seizures 88.",
      "key": "50a274fc167ea60b2465cb70ee8e18cd",
      "line": 652,
      "relation": "increases",
      "source": 92,
      "target": 148
    },
    {
      "key": "63ab7f820576550f999f13baca16fd92",
      "relation": "partOf",
      "source": 116,
      "target": 92
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "Moreover, antibodies against the α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) receptor can have a pathological role: administration of human pathogenic antibodies against the AMPA receptor subunit GluA2 impairs long-term synaptic plasticity in vitro and affects learning and memory in mice in vivo 89. ",
      "key": "b15d71dc46529b042fe3c2e5e0cd3bfc",
      "line": 658,
      "relation": "decreases",
      "source": 93,
      "target": 62
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Species": {
          "10095": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "Moreover, antibodies against the α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) receptor can have a pathological role: administration of human pathogenic antibodies against the AMPA receptor subunit GluA2 impairs long-term synaptic plasticity in vitro and affects learning and memory in mice in vivo 89. ",
      "key": "f83724a87a48933a292dcf48ab38c23d",
      "line": 660,
      "relation": "decreases",
      "source": 93,
      "target": 52
    },
    {
      "key": "b7f08c022be92cc415102fba09b90027",
      "relation": "partOf",
      "source": 117,
      "target": 93
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "Furthermore, antibodies that cross-react with the NMDA receptor have been found in patients with neuropsychiatric systemic lupus erythematosus, and these antibodies cause neuronal damage via activated microglia and complement component C1q when administered to mice 93,94.",
      "key": "c489ff21550cf54a94c1c93f0ee7dc1b",
      "line": 683,
      "relation": "increases",
      "source": 146,
      "target": 94
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "Furthermore, antibodies that cross-react with the NMDA receptor have been found in patients with neuropsychiatric systemic lupus erythematosus, and these antibodies cause neuronal damage via activated microglia and complement component C1q when administered to mice 93,94.",
      "key": "072f47126cab83d38c29a92703015893",
      "line": 684,
      "relation": "increases",
      "source": 94,
      "target": 53
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "Furthermore, antibodies that cross-react with the NMDA receptor have been found in patients with neuropsychiatric systemic lupus erythematosus, and these antibodies cause neuronal damage via activated microglia and complement component C1q when administered to mice 93,94.",
      "key": "19ab7117cef30374626c0d7ee084f2b1",
      "line": 685,
      "relation": "increases",
      "source": 94,
      "target": 98
    },
    {
      "key": "6b1d24bb5e33bde3b840d70cb6eae31b",
      "relation": "partOf",
      "source": 118,
      "target": 94
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "Independent of immune pathogenesis, glutamate receptor hypofunction has been proposed as a key factor in the development of schizophrenia 98.",
      "key": "31ab3163f676872e380cc662365a595f",
      "line": 693,
      "relation": "positiveCorrelation",
      "source": 118,
      "target": 151
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "Furthermore, extensive studies of cytokine profiles in disorders such as schizophrenia, depression, suicidal ideation and post-traumatic stress disorder reveal wide-ranging dysregulation of mainly pro-inflammatory markers, in particular IL-6, IL-2 receptor, IL-1β, IL-17 A and C-reactive protein (CRP) 103–107.",
      "key": "a3f7b4c89855e05e77fcf1cfd0f40a5d",
      "line": 699,
      "relation": "negativeCorrelation",
      "source": 109,
      "target": 151
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "Furthermore, extensive studies of cytokine profiles in disorders such as schizophrenia, depression, suicidal ideation and post-traumatic stress disorder reveal wide-ranging dysregulation of mainly pro-inflammatory markers, in particular IL-6, IL-2 receptor, IL-1β, IL-17 A and C-reactive protein (CRP) 103–107.",
      "key": "d7205bd319530c5e737a60bf2daf8bfc",
      "line": 704,
      "relation": "negativeCorrelation",
      "source": 109,
      "target": 136
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "Furthermore, extensive studies of cytokine profiles in disorders such as schizophrenia, depression, suicidal ideation and post-traumatic stress disorder reveal wide-ranging dysregulation of mainly pro-inflammatory markers, in particular IL-6, IL-2 receptor, IL-1β, IL-17 A and C-reactive protein (CRP) 103–107.",
      "key": "6437cf8d5b1240ef09eeedbafd2a9ab7",
      "line": 709,
      "relation": "negativeCorrelation",
      "source": 109,
      "target": 141
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "Furthermore, extensive studies of cytokine profiles in disorders such as schizophrenia, depression, suicidal ideation and post-traumatic stress disorder reveal wide-ranging dysregulation of mainly pro-inflammatory markers, in particular IL-6, IL-2 receptor, IL-1β, IL-17 A and C-reactive protein (CRP) 103–107.",
      "key": "8e192ca5c4ce65850977723ac0ed4c29",
      "line": 701,
      "relation": "negativeCorrelation",
      "source": 107,
      "target": 151
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "Furthermore, extensive studies of cytokine profiles in disorders such as schizophrenia, depression, suicidal ideation and post-traumatic stress disorder reveal wide-ranging dysregulation of mainly pro-inflammatory markers, in particular IL-6, IL-2 receptor, IL-1β, IL-17 A and C-reactive protein (CRP) 103–107.",
      "key": "8deb8d8690aa14faa4e5ba10e0eed4db",
      "line": 706,
      "relation": "negativeCorrelation",
      "source": 107,
      "target": 136
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "Furthermore, extensive studies of cytokine profiles in disorders such as schizophrenia, depression, suicidal ideation and post-traumatic stress disorder reveal wide-ranging dysregulation of mainly pro-inflammatory markers, in particular IL-6, IL-2 receptor, IL-1β, IL-17 A and C-reactive protein (CRP) 103–107.",
      "key": "59eb4e8493d6956cca85d8619b6d9b89",
      "line": 711,
      "relation": "negativeCorrelation",
      "source": 107,
      "target": 141
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "In mice, autism-like behaviour in offspring requires the presence of maternal RORgammat-positive TH17 cells and IL-17a downstream of IL-6 (reF.115).",
      "key": "db670146e0c089709bfd7c2d7ac73747",
      "line": 754,
      "relation": "increases",
      "source": 107,
      "target": 162
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "Furthermore, extensive studies of cytokine profiles in disorders such as schizophrenia, depression, suicidal ideation and post-traumatic stress disorder reveal wide-ranging dysregulation of mainly pro-inflammatory markers, in particular IL-6, IL-2 receptor, IL-1β, IL-17 A and C-reactive protein (CRP) 103–107.",
      "key": "6c4e6244524b3ddbd3ddcf116b4b4894",
      "line": 702,
      "relation": "negativeCorrelation",
      "source": 103,
      "target": 151
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "Furthermore, extensive studies of cytokine profiles in disorders such as schizophrenia, depression, suicidal ideation and post-traumatic stress disorder reveal wide-ranging dysregulation of mainly pro-inflammatory markers, in particular IL-6, IL-2 receptor, IL-1β, IL-17 A and C-reactive protein (CRP) 103–107.",
      "key": "5dd0864b8a7d61acff8ccf5a16cf44a7",
      "line": 707,
      "relation": "negativeCorrelation",
      "source": 103,
      "target": 136
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "Furthermore, extensive studies of cytokine profiles in disorders such as schizophrenia, depression, suicidal ideation and post-traumatic stress disorder reveal wide-ranging dysregulation of mainly pro-inflammatory markers, in particular IL-6, IL-2 receptor, IL-1β, IL-17 A and C-reactive protein (CRP) 103–107.",
      "key": "7fa26f9338b3ba06b291406b78eec018",
      "line": 712,
      "relation": "negativeCorrelation",
      "source": 103,
      "target": 141
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "Furthermore, extensive studies of cytokine profiles in disorders such as schizophrenia, depression, suicidal ideation and post-traumatic stress disorder reveal wide-ranging dysregulation of mainly pro-inflammatory markers, in particular IL-6, IL-2 receptor, IL-1β, IL-17 A and C-reactive protein (CRP) 103–107.",
      "key": "869c9cf59cd190e1df473b1ce7a01cd7",
      "line": 708,
      "relation": "negativeCorrelation",
      "source": 141,
      "target": 111
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "Furthermore, extensive studies of cytokine profiles in disorders such as schizophrenia, depression, suicidal ideation and post-traumatic stress disorder reveal wide-ranging dysregulation of mainly pro-inflammatory markers, in particular IL-6, IL-2 receptor, IL-1β, IL-17 A and C-reactive protein (CRP) 103–107.",
      "key": "bd659e0c9af0dc39975c6c51f849411b",
      "line": 709,
      "relation": "negativeCorrelation",
      "source": 141,
      "target": 109
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "Furthermore, extensive studies of cytokine profiles in disorders such as schizophrenia, depression, suicidal ideation and post-traumatic stress disorder reveal wide-ranging dysregulation of mainly pro-inflammatory markers, in particular IL-6, IL-2 receptor, IL-1β, IL-17 A and C-reactive protein (CRP) 103–107.",
      "key": "e68fb9b234a8b77ec93580cee857e812",
      "line": 710,
      "relation": "negativeCorrelation",
      "source": 141,
      "target": 108
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "Furthermore, extensive studies of cytokine profiles in disorders such as schizophrenia, depression, suicidal ideation and post-traumatic stress disorder reveal wide-ranging dysregulation of mainly pro-inflammatory markers, in particular IL-6, IL-2 receptor, IL-1β, IL-17 A and C-reactive protein (CRP) 103–107.",
      "key": "964d2379355d4c2a07df6bfa45fbc609",
      "line": 711,
      "relation": "negativeCorrelation",
      "source": 141,
      "target": 107
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "Furthermore, extensive studies of cytokine profiles in disorders such as schizophrenia, depression, suicidal ideation and post-traumatic stress disorder reveal wide-ranging dysregulation of mainly pro-inflammatory markers, in particular IL-6, IL-2 receptor, IL-1β, IL-17 A and C-reactive protein (CRP) 103–107.",
      "key": "9a7dae8f3b4e4e37ed29f99c3f8fed05",
      "line": 712,
      "relation": "negativeCorrelation",
      "source": 141,
      "target": 103
    },
    {
      "annotations": {
        "Anatomy": {
          "central nervous system": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "Changes in the innate CNS immune compartment have also been associated with psychiatric disorders.",
      "key": "98aa86a99b9c7ebe650f0c3f5a279f5c",
      "line": 718,
      "relation": "association",
      "source": 199,
      "target": 79
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "For example, genetic defects in microglial signalling pathways cause abnormal development of brain circuits and neuropsychiatric symptoms, as in hereditary diffuse leukoencephalopathy with spheroids (HDLS) 109.",
      "key": "486ae80d4f618c4841488338605d7679",
      "line": 724,
      "relation": "negativeCorrelation",
      "source": 174,
      "target": 53
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Gender": {
          "Female": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "A study published in 2017 provides evidence that maternal gut commensal bacteria have a role in IL-17a production in mothers 117.",
      "key": "5df224bdec60ea66193f3e3cb42dcef1",
      "line": 762,
      "relation": "increases",
      "source": 77,
      "target": 107
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Species": {
          "10116": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "In rodents, the role of maternal immune activation in ASD was confirmed at the transcriptome level, in which immune activation in the mother caused dysregulation in the fetal brain expression of genes involved in developmental processes 120.",
      "key": "0997b22da2dbe6bb766f629c94146a55",
      "line": 769,
      "relation": "positiveCorrelation",
      "source": 80,
      "target": 133
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Species": {
          "10116": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "In rodents, the role of maternal immune activation in ASD was confirmed at the transcriptome level, in which immune activation in the mother caused dysregulation in the fetal brain expression of genes involved in developmental processes 120.",
      "key": "eb863e4d7e6e69541e9137bc1c90d3ac",
      "line": 770,
      "relation": "negativeCorrelation",
      "source": 80,
      "target": 49
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Species": {
          "10116": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "In rodents, the role of maternal immune activation in ASD was confirmed at the transcriptome level, in which immune activation in the mother caused dysregulation in the fetal brain expression of genes involved in developmental processes 120.",
      "key": "f38fb1244ae477ebbfcb2c9b7b311e43",
      "line": 770,
      "relation": "negativeCorrelation",
      "source": 49,
      "target": 80
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "Cytokine signalling is not the only aspect of maternal immunity that affects the developing fetal brain — B cell-mediated immune responses and production of antibodies can also have effects.",
      "key": "6b4bc0e6a1ccaac2a85d88b3e1fb4081",
      "line": 776,
      "object": {
        "modifier": "Activity"
      },
      "relation": "association",
      "source": 49,
      "target": 9
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "Cytokine signalling is not the only aspect of maternal immunity that affects the developing fetal brain — B cell-mediated immune responses and production of antibodies can also have effects.",
      "key": "58c4aab457c4a05033101a578cfd1958",
      "line": 777,
      "relation": "association",
      "source": 49,
      "target": 75
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Species": {
          "9539": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "Targets for these antibodies include proteins with functions in neurodevelopment, such as contactin-associated protein-like 2 (CASPR2) 122,124.",
      "key": "007b4a7fca99f54971a6872e7c4dd253",
      "line": 785,
      "relation": "increases",
      "source": 95,
      "target": 182
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Species": {
          "9539": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "Targets for these antibodies include proteins with functions in neurodevelopment, such as contactin-associated protein-like 2 (CASPR2) 122,124.",
      "key": "33233e8c7f4eedb9c613f9c343a7b6a9",
      "line": 786,
      "relation": "increases",
      "source": 95,
      "target": 188
    },
    {
      "key": "4aa15be07596e6cbaa27f4a9ad0e3ee4",
      "relation": "partOf",
      "source": 102,
      "target": 95
    },
    {
      "key": "9d28fe0810f79cf5186672f9e470e11e",
      "relation": "partOf",
      "source": 123,
      "target": 95
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "For example, the MHC-resident complement C4 cluster has been implicated in the risk of schizophrenia 128,129.",
      "key": "18c29c8d61aac8a60cdce18a2c20be89",
      "line": 792,
      "relation": "positiveCorrelation",
      "source": 100,
      "target": 151
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "Routinely used treatments for acute exacerbations include steroids, plasmapheresis, intravenous immunoglobulin, cyclophosphamide and B cell-depleting monoclonal antibodies; a broadening range of disease-modifying drugs is emerging from the development of therapies for MS (Box 2).",
      "key": "37655dc047bda22b8b4179e4de9522b7",
      "line": 797,
      "relation": "decreases",
      "source": 38,
      "target": 137
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "Routinely used treatments for acute exacerbations include steroids, plasmapheresis, intravenous immunoglobulin, cyclophosphamide and B cell-depleting monoclonal antibodies; a broadening range of disease-modifying drugs is emerging from the development of therapies for MS (Box 2).",
      "key": "61b8ee39899b00b51888c37bd9b36a51",
      "line": 798,
      "relation": "decreases",
      "source": 201,
      "target": 137
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "Routinely used treatments for acute exacerbations include steroids, plasmapheresis, intravenous immunoglobulin, cyclophosphamide and B cell-depleting monoclonal antibodies; a broadening range of disease-modifying drugs is emerging from the development of therapies for MS (Box 2).",
      "key": "333e604bca62858c32f4bf92263428ab",
      "line": 799,
      "relation": "decreases",
      "source": 89,
      "target": 137
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "Routinely used treatments for acute exacerbations include steroids, plasmapheresis, intravenous immunoglobulin, cyclophosphamide and B cell-depleting monoclonal antibodies; a broadening range of disease-modifying drugs is emerging from the development of therapies for MS (Box 2).",
      "key": "8b2626e2e75d99255cefcfc4f15a2ae2",
      "line": 800,
      "relation": "decreases",
      "source": 3,
      "target": 137
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Autoimmune Diseases": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "Immunosuppression is also an established treatment strategy for autoimmune encephalitis, but clinical studies of such treatments for psychiatric diseases are still in progress.",
      "key": "946e8ac924d211448d61687e2e56d37b",
      "line": 806,
      "relation": "decreases",
      "source": 1,
      "target": 148
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Depression": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "For example, a meta-analysis showed that SSRIs reduce levels of IL-1β and IL-6 in patients with depression 140.",
      "key": "1b9f45e5ac1e0258f79c4b23a3c11784",
      "line": 813,
      "relation": "decreases",
      "source": 21,
      "target": 111
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Depression": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "For example, a meta-analysis showed that SSRIs reduce levels of IL-1β and IL-6 in patients with depression 140.",
      "key": "bd6fc868ff6da4c45a610bfa70462706",
      "line": 814,
      "relation": "decreases",
      "source": 21,
      "target": 108
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Species": {
          "10116": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "In rats, the microglia inhibitor minocycline improved symptoms of depression in the forced swimming test 143, an observation that is consistent with reports that microglia are overactivated in depression 112.",
      "key": "c20c92142839ac171e63c8c1e4b06854",
      "line": 821,
      "relation": "decreases",
      "source": 4,
      "target": 35
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Species": {
          "10116": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "In rats, the microglia inhibitor minocycline improved symptoms of depression in the forced swimming test 143, an observation that is consistent with reports that microglia are overactivated in depression 112.",
      "key": "407d7484e57d0d43a3609ddaead0f37b",
      "line": 822,
      "relation": "decreases",
      "source": 4,
      "target": 136
    },
    {
      "key": "bafc4c6ce209a2a469a78f4b12ae44c1",
      "relation": "partOf",
      "source": 4,
      "target": 96
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "Minocycline also had positive effects as an adjunctive treatment to risperidone in children with ASD 145, although not as a single medication in a small pilot study 146.",
      "key": "72ad2e6975e01635e0cf615d7d2542a1",
      "line": 831,
      "relation": "causesNoChange",
      "source": 4,
      "target": 133
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "Minocycline also had positive effects as an adjunctive treatment to risperidone in children with ASD 145, although not as a single medication in a small pilot study 146.",
      "key": "5ca6cd732e8d2de86ccbb0fc07733821",
      "line": 830,
      "relation": "negativeCorrelation",
      "source": 96,
      "target": 133
    },
    {
      "key": "51517f13a42d9a0a1b3b6ccb0f9b3bcc",
      "relation": "partOf",
      "source": 5,
      "target": 96
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "Furthermore, in depression, anti-inflammatory treatment with the TNF antagonist infliximab had beneficial effects in patients with treatment-resistant depression and high baseline levels of inflammatory biomarkers 147.",
      "key": "938e9219a9c868b3e6af0de62dc1ed08",
      "line": 837,
      "relation": "decreases",
      "source": 39,
      "target": 115
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "Furthermore, in depression, anti-inflammatory treatment with the TNF antagonist infliximab had beneficial effects in patients with treatment-resistant depression and high baseline levels of inflammatory biomarkers 147.",
      "key": "c8f3383383c3c4fc2504d93ae50f809d",
      "line": 838,
      "relation": "negativeCorrelation",
      "source": 39,
      "target": 136
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "A well-recognized risk factor for exacerbation in MS and many psychiatric disorders is psychosocial stress.",
      "key": "b46221dcd5f79d1532870b5c3f5ea86b",
      "line": 843,
      "relation": "positiveCorrelation",
      "source": 186,
      "target": 177
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "A well-recognized risk factor for exacerbation in MS and many psychiatric disorders is psychosocial stress.",
      "key": "08b251a122e8a43aae0be1aa79410783",
      "line": 844,
      "relation": "positiveCorrelation",
      "source": 186,
      "target": 137
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "Some evidence suggests that the association between psychiatric disorders and stress is mediated, at least in part, by neuroinflammatory processes, including microglial activation.",
      "key": "16cfe6af8fe4def3d0381fee4be4a193",
      "line": 849,
      "relation": "increases",
      "source": 186,
      "target": 53
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "Some evidence suggests that the association between psychiatric disorders and stress is mediated, at least in part, by neuroinflammatory processes, including microglial activation.",
      "key": "d732b6696f1aaeb62d6bd08c1e5dcd3b",
      "line": 851,
      "relation": "increases",
      "source": 56,
      "target": 177
    },
    {
      "annotations": {
        "Anatomy": {
          "nucleus accumbens": true
        },
        "Confidence": {
          "High": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "In a mouse model of chronic social defeat stress, BBB integrity was altered in the nucleus accumbens owing to downregulation of the tight junction protein claudin 5, thereby allowing influx of IL-6 into the brain parenchyma 153.",
      "key": "efee3aa3d4b98fcc4212834d25870050",
      "line": 858,
      "object": {
        "modifier": "Degradation"
      },
      "relation": "increases",
      "source": 190,
      "target": 11
    },
    {
      "annotations": {
        "Anatomy": {
          "brain": true,
          "parenchyma": true
        },
        "Confidence": {
          "High": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "In a mouse model of chronic social defeat stress, BBB integrity was altered in the nucleus accumbens owing to downregulation of the tight junction protein claudin 5, thereby allowing influx of IL-6 into the brain parenchyma 153.",
      "key": "8b27ba12c6caea89b0c33425df7a5f4f",
      "line": 861,
      "relation": "decreases",
      "source": 101,
      "target": 111
    },
    {
      "annotations": {
        "Anatomy": {
          "cerebral cortex": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Leboyer M",
          "Pape K",
          "Tamouza R",
          "Zipp F"
        ],
        "date": "2019-06-01",
        "db": "PubMed",
        "db_id": "30988501",
        "db_name": "Immunoneuropsychiatry - novel perspectives on brain disorders.",
        "first": "Pape K",
        "journal": "Nature reviews. Neurology",
        "last": "Zipp F",
        "pages": "317-328",
        "volume": "15"
      },
      "evidence": "Our recent studies indicate that the cortical network responds to an inflammatory attack with a TNF-dependent increase in cortical synaptic strength 65.",
      "key": "ed7d8157a39124def309680db4dc581f",
      "line": 871,
      "relation": "decreases",
      "source": 23,
      "target": 198
    }
  ],
  "multigraph": true,
  "nodes": [
    {
      "bel": "a(CHEBI:\"amyloid-beta\")",
      "concept": {
        "name": "amyloid-beta",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "e9557ea6ec74113b73fe23f4bd76b524"
    },
    {
      "bel": "a(CHEBI:\"immunosuppressive agent\")",
      "concept": {
        "name": "immunosuppressive agent",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "f813536ea7474c939e456e64c9be7a88"
    },
    {
      "bel": "a(CHEBI:\"reactive oxygen species\")",
      "concept": {
        "name": "reactive oxygen species",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "39a67bec2ea8cb7a2bec39cf66e565ba"
    },
    {
      "bel": "a(CHEBI:cyclophosphamide)",
      "concept": {
        "name": "cyclophosphamide",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "3254d9548d444bdbb12fc9b57014fce5"
    },
    {
      "bel": "a(CHEBI:minocycline)",
      "concept": {
        "name": "minocycline",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "125bcfaabefb343792e7934d0acfd34b"
    },
    {
      "bel": "a(CHEBI:risperidone)",
      "concept": {
        "name": "risperidone",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "b845bb28cb099073b51d32e2834da87a"
    },
    {
      "bel": "a(GO:\"myelin sheath\")",
      "concept": {
        "name": "myelin sheath",
        "namespace": "GO"
      },
      "function": "Abundance",
      "id": "bf6321e3579542c2ca199fdb7abf3275"
    },
    {
      "bel": "a(GO:\"postsynaptic density\")",
      "concept": {
        "name": "postsynaptic density",
        "namespace": "GO"
      },
      "function": "Abundance",
      "id": "572f1806c15d16c34e0870374ef1df23"
    },
    {
      "bel": "a(MESH:\"Antigen-Presenting Cells\")",
      "concept": {
        "name": "Antigen-Presenting Cells",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "8df8b36b26739aaa829426b306bfa1d7"
    },
    {
      "bel": "a(MESH:\"B-Lymphocytes\")",
      "concept": {
        "name": "B-Lymphocytes",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "f58463c9771eaea79cce530465284035"
    },
    {
      "bel": "a(MESH:\"B-Lymphocytes, Regulatory\")",
      "concept": {
        "name": "B-Lymphocytes, Regulatory",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "8361d996ea5a01782cb8ccb7c9ab2621"
    },
    {
      "bel": "a(MESH:\"Blood-Brain Barrier\")",
      "concept": {
        "name": "Blood-Brain Barrier",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "63dcf0f7f45e2c3862eb5a77da5f2627"
    },
    {
      "bel": "a(MESH:\"Central Nervous System\")",
      "concept": {
        "name": "Central Nervous System",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "9480f2a1fd508f09840a01c1083e635e"
    },
    {
      "bel": "a(MESH:\"Cerebral Cortex\")",
      "concept": {
        "name": "Cerebral Cortex",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "077de1b5bd239fcc1b5ed7bec5aa46cf"
    },
    {
      "bel": "a(MESH:\"Extracellular Vesicles\")",
      "concept": {
        "name": "Extracellular Vesicles",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "2ed93ef15d2794861a2b0dd8aba69233"
    },
    {
      "bel": "a(MESH:\"Gray Matter\")",
      "concept": {
        "name": "Gray Matter",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "ec3d8cd3fe21e400949f6f15da400cd6"
    },
    {
      "bel": "a(MESH:\"Herpesvirus 1, Human\")",
      "concept": {
        "name": "Herpesvirus 1, Human",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "0eb82c0c6d7fd90f9c2c26d664bd706e"
    },
    {
      "bel": "a(MESH:\"Herpesvirus 2, Human\")",
      "concept": {
        "name": "Herpesvirus 2, Human",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "bc4861b847882bb9895cb6f131e6a1ca"
    },
    {
      "bel": "a(MESH:\"Inflammation Mediators\")",
      "concept": {
        "name": "Inflammation Mediators",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "6d9dce0dcdafa0aad2943672efff259d"
    },
    {
      "bel": "a(MESH:\"Neural Pathways\")",
      "concept": {
        "name": "Neural Pathways",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "839bb84d9f92a92d8528b3eef2b9c0c3"
    },
    {
      "bel": "a(MESH:\"Pathogen-Associated Molecular Pattern Molecules\")",
      "concept": {
        "name": "Pathogen-Associated Molecular Pattern Molecules",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "f3c8c3a0ab820bc41977da2994e2c838"
    },
    {
      "bel": "a(MESH:\"Serotonin Uptake Inhibitors\")",
      "concept": {
        "name": "Serotonin Uptake Inhibitors",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "29eb0125030d15a89d688a814b7bdd49"
    },
    {
      "bel": "a(MESH:\"Streptococcus pyogenes\")",
      "concept": {
        "name": "Streptococcus pyogenes",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "ad6e1a764cc1583422860d1cf7122832"
    },
    {
      "bel": "a(MESH:\"Synaptic Membranes\")",
      "concept": {
        "name": "Synaptic Membranes",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "2fc5276dc5e4eb9f2dab0a6e05c1be0f"
    },
    {
      "bel": "a(MESH:\"T-Lymphocytes\")",
      "concept": {
        "name": "T-Lymphocytes",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "04840e346c8f8e46d6d4e5ed8f1b84c5"
    },
    {
      "bel": "a(MESH:\"T-Lymphocytes, Cytotoxic\")",
      "concept": {
        "name": "T-Lymphocytes, Cytotoxic",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "57d8711b0db2cb722db07f5b2c07396c"
    },
    {
      "bel": "a(MESH:\"T-Lymphocytes, Regulatory\")",
      "concept": {
        "name": "T-Lymphocytes, Regulatory",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "fcc3fa9dfeeae3748755e8f546e23b9d"
    },
    {
      "bel": "a(MESH:\"Th17 Cells\")",
      "concept": {
        "name": "Th17 Cells",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "03f266f4a7d5b3028dd2af8637fe909f"
    },
    {
      "bel": "a(MESH:\"Th2 Cells\")",
      "concept": {
        "name": "Th2 Cells",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "f9aac88ef998325c524a95883639e711"
    },
    {
      "bel": "a(MESH:\"Waste Products\")",
      "concept": {
        "name": "Waste Products",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "2bab4af881775f3b4b853b3ee42eb957"
    },
    {
      "bel": "a(MESH:\"White Matter\")",
      "concept": {
        "name": "White Matter",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "6e71bab67d66a2370343d976a22bf3b0"
    },
    {
      "bel": "a(MESH:Autoantibodies)",
      "concept": {
        "name": "Autoantibodies",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "6a2d912f8f1c305c45fcbe297eaf4f8a"
    },
    {
      "bel": "a(MESH:Brain)",
      "concept": {
        "name": "Brain",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "122591e1e5a28ece8ac1124593ee701f"
    },
    {
      "bel": "a(MESH:Chemokines)",
      "concept": {
        "name": "Chemokines",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "9a02b9191c070440d07b7fd83cdc58e1"
    },
    {
      "bel": "a(MESH:Cytokines)",
      "concept": {
        "name": "Cytokines",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "0d3c01297f25a34285f54b350178a231"
    },
    {
      "bel": "a(MESH:Microglia)",
      "concept": {
        "name": "Microglia",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "4ef490b325b2b1e33e41b4e22e1bd8c6"
    },
    {
      "bel": "a(MESH:Neurons)",
      "concept": {
        "name": "Neurons",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "c429b8780142c504cf23cacfc2fa2b09"
    },
    {
      "bel": "a(MESH:Neuropil)",
      "concept": {
        "name": "Neuropil",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "e8fe7ba61a1d53d0b3095edd990b03f8"
    },
    {
      "bel": "a(MESH:Steroids)",
      "concept": {
        "name": "Steroids",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "31626ec2bc77dc4219f545ac1e463b05"
    },
    {
      "bel": "a(PUBCHEM:135305802)",
      "concept": {
        "name": "135305802",
        "namespace": "PUBCHEM"
      },
      "function": "Abundance",
      "id": "0942cce05f575e1a55745f0c9bd31590"
    },
    {
      "bel": "bp(GO:\"activation of immune response\")",
      "concept": {
        "name": "activation of immune response",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "6c658c37b5d3a65c439715acd65814f7"
    },
    {
      "bel": "bp(GO:\"activation of innate immune response\")",
      "concept": {
        "name": "activation of innate immune response",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "d3f5a6366977e2c3eb99648eed624f6f"
    },
    {
      "bel": "bp(GO:\"axonal transport\")",
      "concept": {
        "name": "axonal transport",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "c9d614fb05004498d4069f216f0458c8"
    },
    {
      "bel": "bp(GO:\"brain development\")",
      "concept": {
        "name": "brain development",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "ac0c7c6bcd68b7fc8d43fa1e094e68f6"
    },
    {
      "bel": "bp(GO:\"cell migration\")",
      "concept": {
        "name": "cell migration",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "26a5af4491116059185aaf203742481a"
    },
    {
      "bel": "bp(GO:\"central nervous system development\")",
      "concept": {
        "name": "central nervous system development",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "7e4762f396be03c27440217d4b8ab6dc"
    },
    {
      "bel": "bp(GO:\"complement-mediated synapse pruning\")",
      "concept": {
        "name": "complement-mediated synapse pruning",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "1b694c3409905de5793d3ede0b255644"
    },
    {
      "bel": "bp(GO:\"cytokine production\")",
      "concept": {
        "name": "cytokine production",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "a7cc5a9048ceb3474610a0f305bbbad6"
    },
    {
      "bel": "bp(GO:\"cytokine secretion\")",
      "concept": {
        "name": "cytokine secretion",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "aef7ac09ab6fe38f13141e78004d3605"
    },
    {
      "bel": "bp(GO:\"embryonic brain development\")",
      "concept": {
        "name": "embryonic brain development",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "c2982bcb1ece0b67d7d043e601cbb55e"
    },
    {
      "bel": "bp(GO:\"immune system process\")",
      "concept": {
        "name": "immune system process",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "0c674851805026ff3f3bb85d9f6dffea"
    },
    {
      "bel": "bp(GO:\"inflammatory response\")",
      "concept": {
        "name": "inflammatory response",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "abd32f6c5cca606061975532840db260"
    },
    {
      "bel": "bp(GO:\"learning or memory\")",
      "concept": {
        "name": "learning or memory",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "f7990d886000f2ae69441a960a7d6236"
    },
    {
      "bel": "bp(GO:\"microglial cell activation\")",
      "concept": {
        "name": "microglial cell activation",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "3c02f523866973a040dc6bfa5b372b2e"
    },
    {
      "bel": "bp(GO:\"monoamine transport\")",
      "concept": {
        "name": "monoamine transport",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "b08dd83db503610c8a71a4e73971b0a0"
    },
    {
      "bel": "bp(GO:\"motor learning\")",
      "concept": {
        "name": "motor learning",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "4cc09f11616f2ce7bbd23c6cfc683706"
    },
    {
      "bel": "bp(GO:\"neuroinflammatory response\")",
      "concept": {
        "name": "neuroinflammatory response",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "6e2a3e6619ccd33f9e976253c861dbb6"
    },
    {
      "bel": "bp(GO:\"neuron cellular homeostasis\")",
      "concept": {
        "name": "neuron cellular homeostasis",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "bcb1ef79e67eedac68fecb0000bc4a7f"
    },
    {
      "bel": "bp(GO:\"neuron-glial cell signaling\")",
      "concept": {
        "name": "neuron-glial cell signaling",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "ac4e653b597bbeba307fb0c393e0fb65"
    },
    {
      "bel": "bp(GO:\"regulation of action potential firing rate\")",
      "concept": {
        "name": "regulation of action potential firing rate",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "152bd9dd7d1f3ba6dbd683200c52dba8"
    },
    {
      "bel": "bp(GO:\"regulation of gene expression, epigenetic\")",
      "concept": {
        "name": "regulation of gene expression, epigenetic",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "89fe07b3f170dbb2d867f43c0ee0d095"
    },
    {
      "bel": "bp(GO:\"regulation of neuronal synaptic plasticity\")",
      "concept": {
        "name": "regulation of neuronal synaptic plasticity",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "c547001e8cd63956c88a4ee9fc4d68c6"
    },
    {
      "bel": "bp(GO:\"regulation of synaptic plasticity\")",
      "concept": {
        "name": "regulation of synaptic plasticity",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "03639a6f8b863bc0519adc6ebb4bab7d"
    },
    {
      "bel": "bp(GO:\"response to stress\")",
      "concept": {
        "name": "response to stress",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "79dc63792aaad9fcb821c31bd0d55d58"
    },
    {
      "bel": "bp(GO:\"social behavior\")",
      "concept": {
        "name": "social behavior",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "a29e46e4bfd179ce4bcaf8020c64b485"
    },
    {
      "bel": "bp(GO:\"synaptic signaling\")",
      "concept": {
        "name": "synaptic signaling",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "47e244f71f5d21a426ba920c40e7b9ed"
    },
    {
      "bel": "bp(GO:\"synaptic transmission, glutamatergic\")",
      "concept": {
        "name": "synaptic transmission, glutamatergic",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "5877395a7b5611ac3adf769c874bf33b"
    },
    {
      "bel": "bp(GO:autophagy)",
      "concept": {
        "name": "autophagy",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "9efc965fac6a195d0fad26eecddaac05"
    },
    {
      "bel": "bp(GO:cognition)",
      "concept": {
        "name": "cognition",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "24220ec2073c35bcd945681ee9c6ea38"
    },
    {
      "bel": "bp(GO:learning)",
      "concept": {
        "name": "learning",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "75fc4f4e732353b87f83a4a8174ffb29"
    },
    {
      "bel": "bp(GO:neurogenesis)",
      "concept": {
        "name": "neurogenesis",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "a6081bcfdb54d676fc8fec30c017475f"
    },
    {
      "bel": "bp(GO:pathogenesis)",
      "concept": {
        "name": "pathogenesis",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "13fffc1eff1da79aaf1a185b529f9c1b"
    },
    {
      "bel": "bp(GO:phagocytosis)",
      "concept": {
        "name": "phagocytosis",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "7a964edef32244471f3c9f79c2cdfbaf"
    },
    {
      "bel": "bp(HP:\"Autoimmune antibody positivity\")",
      "concept": {
        "name": "Autoimmune antibody positivity",
        "namespace": "HP"
      },
      "function": "BiologicalProcess",
      "id": "f56945b2d7bfbf77ae00483fe221a775"
    },
    {
      "bel": "bp(MESH:\"Adaptive Immunity\")",
      "concept": {
        "name": "Adaptive Immunity",
        "namespace": "MESH"
      },
      "function": "BiologicalProcess",
      "id": "79a63eee9cdc077e74d464de3d03ae28"
    },
    {
      "bel": "bp(MESH:\"Antibody Formation\")",
      "concept": {
        "name": "Antibody Formation",
        "namespace": "MESH"
      },
      "function": "BiologicalProcess",
      "id": "084e453b3506a56910068e5bf9ac4f97"
    },
    {
      "bel": "bp(MESH:\"Antigen Presentation\")",
      "concept": {
        "name": "Antigen Presentation",
        "namespace": "MESH"
      },
      "function": "BiologicalProcess",
      "id": "70d7c3396a42958f2b9e3ffe1ce8193e"
    },
    {
      "bel": "bp(MESH:\"Gastrointestinal Microbiome\")",
      "concept": {
        "name": "Gastrointestinal Microbiome",
        "namespace": "MESH"
      },
      "function": "BiologicalProcess",
      "id": "ba07184c75affc4a0bbe7d34737db10e"
    },
    {
      "bel": "bp(MESH:\"Immunity, Cellular\")",
      "concept": {
        "name": "Immunity, Cellular",
        "namespace": "MESH"
      },
      "function": "BiologicalProcess",
      "id": "0b2c65440a339f878183a42c9cbe1ee2"
    },
    {
      "bel": "bp(MESH:\"Immunity, Innate\")",
      "concept": {
        "name": "Immunity, Innate",
        "namespace": "MESH"
      },
      "function": "BiologicalProcess",
      "id": "c30d588927b61157e797de1007ac6927"
    },
    {
      "bel": "bp(MESH:\"Immunity, Maternally-Acquired\")",
      "concept": {
        "name": "Immunity, Maternally-Acquired",
        "namespace": "MESH"
      },
      "function": "BiologicalProcess",
      "id": "29843ebb7e6989dd21c82f5fb19703e4"
    },
    {
      "bel": "bp(MESH:\"Immunologic Surveillance\")",
      "concept": {
        "name": "Immunologic Surveillance",
        "namespace": "MESH"
      },
      "function": "BiologicalProcess",
      "id": "2a3b5f511dc32e48aa8b9fc17ee2a82c"
    },
    {
      "bel": "bp(MESH:\"Molecular Mimicry\")",
      "concept": {
        "name": "Molecular Mimicry",
        "namespace": "MESH"
      },
      "function": "BiologicalProcess",
      "id": "85dfec86c9fc2f0fcc22f393e7aa04f7"
    },
    {
      "bel": "bp(MESH:\"Transendothelial and Transepithelial Migration\")",
      "concept": {
        "name": "Transendothelial and Transepithelial Migration",
        "namespace": "MESH"
      },
      "function": "BiologicalProcess",
      "id": "b51d5b4e993d69354b82edb87e0cb066"
    },
    {
      "bel": "bp(MESH:Neuroprotection)",
      "concept": {
        "name": "Neuroprotection",
        "namespace": "MESH"
      },
      "function": "BiologicalProcess",
      "id": "94345c5831649e39b0f93286f5357249"
    },
    {
      "bel": "bp(MESH:Sleep)",
      "concept": {
        "name": "Sleep",
        "namespace": "MESH"
      },
      "function": "BiologicalProcess",
      "id": "45e85e59d839c13db59285592bd055bc"
    },
    {
      "bel": "bp(MESH:Survival)",
      "concept": {
        "name": "Survival",
        "namespace": "MESH"
      },
      "function": "BiologicalProcess",
      "id": "ad50c73c99a3c0e86f73547ff587f04f"
    },
    {
      "bel": "complex(GO:\"MHC class II protein complex\")",
      "concept": {
        "name": "MHC class II protein complex",
        "namespace": "GO"
      },
      "function": "Complex",
      "id": "0f51ffa691ca81a3d99f8b19ff2b1cdf"
    },
    {
      "bel": "complex(GO:\"NADPH oxidase complex\")",
      "concept": {
        "name": "NADPH oxidase complex",
        "namespace": "GO"
      },
      "function": "Complex",
      "id": "b84c213a626b517af09c975f47402f5b"
    },
    {
      "bel": "complex(GO:\"immunoglobulin complex\")",
      "concept": {
        "name": "immunoglobulin complex",
        "namespace": "GO"
      },
      "function": "Complex",
      "id": "5413821c04f8d591fce4a58eea7a4fc6"
    },
    {
      "bel": "complex(MESH:Inflammasomes)",
      "concept": {
        "name": "Inflammasomes",
        "namespace": "MESH"
      },
      "function": "Complex",
      "id": "47509916150293ffd07bebb1a0241a11"
    },
    {
      "bel": "complex(a(MESH:Autoantibodies), a(MESH:Neuropil))",
      "function": "Complex",
      "id": "749f1da3157dd5d5c51f164614bfbe4a",
      "members": [
        {
          "bel": "a(MESH:Autoantibodies)",
          "concept": {
            "name": "Autoantibodies",
            "namespace": "MESH"
          },
          "function": "Abundance",
          "id": "6a2d912f8f1c305c45fcbe297eaf4f8a"
        },
        {
          "bel": "a(MESH:Neuropil)",
          "concept": {
            "name": "Neuropil",
            "namespace": "MESH"
          },
          "function": "Abundance",
          "id": "e8fe7ba61a1d53d0b3095edd990b03f8"
        }
      ]
    },
    {
      "bel": "complex(a(MESH:Autoantibodies), p(HGNCGENEFAMILY:\"Gamma-aminobutyric acid type A receptor subunits\"))",
      "function": "Complex",
      "id": "9a650c540303657f1f0b91e005f071e3",
      "members": [
        {
          "bel": "a(MESH:Autoantibodies)",
          "concept": {
            "name": "Autoantibodies",
            "namespace": "MESH"
          },
          "function": "Abundance",
          "id": "6a2d912f8f1c305c45fcbe297eaf4f8a"
        },
        {
          "bel": "p(HGNCGENEFAMILY:\"Gamma-aminobutyric acid type A receptor subunits\")",
          "concept": {
            "name": "Gamma-aminobutyric acid type A receptor subunits",
            "namespace": "HGNCGENEFAMILY"
          },
          "function": "Protein",
          "id": "07bbf38fb5fa8dd67c15def36559a21d"
        }
      ]
    },
    {
      "bel": "complex(a(MESH:Autoantibodies), p(HGNCGENEFAMILY:\"Glutamate ionotropic receptor AMPA type subunits\"))",
      "function": "Complex",
      "id": "b4d5f486155edfc4cc2635e64800a06f",
      "members": [
        {
          "bel": "a(MESH:Autoantibodies)",
          "concept": {
            "name": "Autoantibodies",
            "namespace": "MESH"
          },
          "function": "Abundance",
          "id": "6a2d912f8f1c305c45fcbe297eaf4f8a"
        },
        {
          "bel": "p(HGNCGENEFAMILY:\"Glutamate ionotropic receptor AMPA type subunits\")",
          "concept": {
            "name": "Glutamate ionotropic receptor AMPA type subunits",
            "namespace": "HGNCGENEFAMILY"
          },
          "function": "Protein",
          "id": "2b014fdb0e42ce7d4f844ac1d4fe4f83"
        }
      ]
    },
    {
      "bel": "complex(a(MESH:Autoantibodies), p(HGNCGENEFAMILY:\"Glutamate ionotropic receptor NMDA type subunits\"))",
      "function": "Complex",
      "id": "a7c53f7a1599b867c3b520415d6e10d0",
      "members": [
        {
          "bel": "a(MESH:Autoantibodies)",
          "concept": {
            "name": "Autoantibodies",
            "namespace": "MESH"
          },
          "function": "Abundance",
          "id": "6a2d912f8f1c305c45fcbe297eaf4f8a"
        },
        {
          "bel": "p(HGNCGENEFAMILY:\"Glutamate ionotropic receptor NMDA type subunits\")",
          "concept": {
            "name": "Glutamate ionotropic receptor NMDA type subunits",
            "namespace": "HGNCGENEFAMILY"
          },
          "function": "Protein",
          "id": "b7afccdb6102ed56132b102ce2e5f6e6"
        }
      ]
    },
    {
      "bel": "complex(p(HGNC:CNTNAP2), p(MESH:\"Immunoglobulin G\"))",
      "function": "Complex",
      "id": "33420e657d01e63b5f0c73221ee3308b",
      "members": [
        {
          "bel": "p(HGNC:CNTNAP2)",
          "concept": {
            "name": "CNTNAP2",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "93fbbd848f15e8c3f42cf71cd61f0d6d"
        },
        {
          "bel": "p(MESH:\"Immunoglobulin G\")",
          "concept": {
            "name": "Immunoglobulin G",
            "namespace": "MESH"
          },
          "function": "Protein",
          "id": "0552597810550378b083a4247508e495"
        }
      ]
    },
    {
      "bel": "composite(a(CHEBI:minocycline), a(CHEBI:risperidone))",
      "function": "Composite",
      "id": "bce6b49907b18f242787f11e9d17a925",
      "members": [
        {
          "bel": "a(CHEBI:minocycline)",
          "concept": {
            "name": "minocycline",
            "namespace": "CHEBI"
          },
          "function": "Abundance",
          "id": "125bcfaabefb343792e7934d0acfd34b"
        },
        {
          "bel": "a(CHEBI:risperidone)",
          "concept": {
            "name": "risperidone",
            "namespace": "CHEBI"
          },
          "function": "Abundance",
          "id": "b845bb28cb099073b51d32e2834da87a"
        }
      ]
    },
    {
      "bel": "p(HGNC:ACKR3)",
      "concept": {
        "name": "ACKR3",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "5a3fba0ea768004b7321287497bd3bee"
    },
    {
      "bel": "p(HGNC:C1QBP)",
      "concept": {
        "name": "C1QBP",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "6e84866553e21038c5a515a7aab6cc64"
    },
    {
      "bel": "p(HGNC:C3)",
      "concept": {
        "name": "C3",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "26a8a2f1cb63e49c899e482f0bcf01f3"
    },
    {
      "bel": "p(HGNC:C4A)",
      "concept": {
        "name": "C4A",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "504298b277f5a364ef1a3ec5cae991a9"
    },
    {
      "bel": "p(HGNC:CLDN5)",
      "concept": {
        "name": "CLDN5",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "c50a998930062beb1f1c4c413cf6d7ca"
    },
    {
      "bel": "p(HGNC:CNTNAP2)",
      "concept": {
        "name": "CNTNAP2",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "93fbbd848f15e8c3f42cf71cd61f0d6d"
    },
    {
      "bel": "p(HGNC:CRP)",
      "concept": {
        "name": "CRP",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "b2238c9ec2ce73112c0f44c8375b7acb"
    },
    {
      "bel": "p(HGNC:CXCR4)",
      "concept": {
        "name": "CXCR4",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "af48f9d33c6072ead628dbb7a01c7ecd"
    },
    {
      "bel": "p(HGNC:IFNA1)",
      "concept": {
        "name": "IFNA1",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "4f6f7fb1b9b394de8c17cfdd5bbcaff0"
    },
    {
      "bel": "p(HGNC:IFNB1)",
      "concept": {
        "name": "IFNB1",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "187da957c4e0c092e01fc85dd9da5fa4"
    },
    {
      "bel": "p(HGNC:IL17A)",
      "concept": {
        "name": "IL17A",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "7565adaa388ec2dccc2d062833d6f622"
    },
    {
      "bel": "p(HGNC:IL1B)",
      "concept": {
        "name": "IL1B",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "cca08112d9fcf1a31015f1dbfc30b04c"
    },
    {
      "bel": "p(HGNC:IL2)",
      "concept": {
        "name": "IL2",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "99fcd5fe54813ead0bd02d8a06f42173"
    },
    {
      "bel": "p(HGNC:IL4)",
      "concept": {
        "name": "IL4",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "4bf986cc68574441e53aac56e3621b28"
    },
    {
      "bel": "p(HGNC:IL6)",
      "concept": {
        "name": "IL6",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "8a1d3c4828c5416eba867c395cc65caa"
    },
    {
      "bel": "p(HGNC:MAPT)",
      "concept": {
        "name": "MAPT",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "7d1009217050e75d549c8c5aa83309a8"
    },
    {
      "bel": "p(HGNC:MAPT, pmod(Ph))",
      "concept": {
        "name": "MAPT",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "a8fb3a87d5a0672c07462bb17c8b0947",
      "variants": [
        {
          "concept": {
            "name": "Ph",
            "namespace": "bel"
          },
          "kind": "pmod"
        }
      ]
    },
    {
      "bel": "p(HGNC:TLR4)",
      "concept": {
        "name": "TLR4",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "4d3aa2ce51d0cd7f2aa9267a9c61f9f7"
    },
    {
      "bel": "p(HGNC:TNF)",
      "concept": {
        "name": "TNF",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "fdc1c1f5a73c3c992b6eb71ce9b6908e"
    },
    {
      "bel": "p(HGNCGENEFAMILY:\"Gamma-aminobutyric acid type A receptor subunits\")",
      "concept": {
        "name": "Gamma-aminobutyric acid type A receptor subunits",
        "namespace": "HGNCGENEFAMILY"
      },
      "function": "Protein",
      "id": "07bbf38fb5fa8dd67c15def36559a21d"
    },
    {
      "bel": "p(HGNCGENEFAMILY:\"Glutamate ionotropic receptor AMPA type subunits\")",
      "concept": {
        "name": "Glutamate ionotropic receptor AMPA type subunits",
        "namespace": "HGNCGENEFAMILY"
      },
      "function": "Protein",
      "id": "2b014fdb0e42ce7d4f844ac1d4fe4f83"
    },
    {
      "bel": "p(HGNCGENEFAMILY:\"Glutamate ionotropic receptor NMDA type subunits\")",
      "concept": {
        "name": "Glutamate ionotropic receptor NMDA type subunits",
        "namespace": "HGNCGENEFAMILY"
      },
      "function": "Protein",
      "id": "b7afccdb6102ed56132b102ce2e5f6e6"
    },
    {
      "bel": "p(HGNCGENEFAMILY:\"Glutamate metabotropic receptors\")",
      "concept": {
        "name": "Glutamate metabotropic receptors",
        "namespace": "HGNCGENEFAMILY"
      },
      "function": "Protein",
      "id": "1c34544bf5678b624a8252fec66c65d9"
    },
    {
      "bel": "p(HGNCGENEFAMILY:\"Purinergic receptors P2X\")",
      "concept": {
        "name": "Purinergic receptors P2X",
        "namespace": "HGNCGENEFAMILY"
      },
      "function": "Protein",
      "id": "770aab4e4741f29e21d098f34ef0363f"
    },
    {
      "bel": "p(INTERPRO:\"Chemokine receptor family\")",
      "concept": {
        "name": "Chemokine receptor family",
        "namespace": "INTERPRO"
      },
      "function": "Protein",
      "id": "59b51a1a6396da3fe7aede6457ea010e"
    },
    {
      "bel": "p(INTERPRO:\"Flavodoxin/nitric oxide synthase\")",
      "concept": {
        "name": "Flavodoxin/nitric oxide synthase",
        "namespace": "INTERPRO"
      },
      "function": "Protein",
      "id": "01babd9b558403590801bc0a8582b080"
    },
    {
      "bel": "p(MESH:\"Immunoglobulin G\")",
      "concept": {
        "name": "Immunoglobulin G",
        "namespace": "MESH"
      },
      "function": "Protein",
      "id": "0552597810550378b083a4247508e495"
    },
    {
      "bel": "p(MESH:\"Receptors, Antigen, T-Cell\")",
      "concept": {
        "name": "Receptors, Antigen, T-Cell",
        "namespace": "MESH"
      },
      "function": "Protein",
      "id": "0a3a43104d3ecb88b1705a651c3625f8"
    },
    {
      "bel": "p(MESH:\"Receptors, Cytokine\")",
      "concept": {
        "name": "Receptors, Cytokine",
        "namespace": "MESH"
      },
      "function": "Protein",
      "id": "5d5ac846cf0e39ea86ac5beb9cca0b27"
    },
    {
      "bel": "p(MESH:Antibodies)",
      "concept": {
        "name": "Antibodies",
        "namespace": "MESH"
      },
      "function": "Protein",
      "id": "0c889f1acd1690024513d943546b9397"
    },
    {
      "bel": "path(CONSO:\"mitochondrial dysfunction\")",
      "concept": {
        "name": "mitochondrial dysfunction",
        "namespace": "CONSO"
      },
      "function": "Pathology",
      "id": "14a330b2e354b7af4f380b05664a5728"
    },
    {
      "bel": "path(CONSO:Neurodegeneration)",
      "concept": {
        "name": "Neurodegeneration",
        "namespace": "CONSO"
      },
      "function": "Pathology",
      "id": "e18248b0d7323caa29b448e45437a1e5"
    },
    {
      "bel": "path(CONSO:neuroinflammation)",
      "concept": {
        "name": "neuroinflammation",
        "namespace": "CONSO"
      },
      "function": "Pathology",
      "id": "b264621022ed4df78748c6c4e198145d"
    },
    {
      "bel": "path(CONSO:neurotoxicity)",
      "concept": {
        "name": "neurotoxicity",
        "namespace": "CONSO"
      },
      "function": "Pathology",
      "id": "f092504a78142cc0cb1a590cf3b073d3"
    },
    {
      "bel": "path(DOID:\"Alzheimer's disease\")",
      "concept": {
        "name": "Alzheimer's disease",
        "namespace": "DOID"
      },
      "function": "Pathology",
      "id": "bab8638a4ae2b144ee036438e0a858da"
    },
    {
      "bel": "path(DOID:\"anxiety disorder\")",
      "concept": {
        "name": "anxiety disorder",
        "namespace": "DOID"
      },
      "function": "Pathology",
      "id": "4c9c378960015f92a5767d57a6af6eb0"
    },
    {
      "bel": "path(DOID:\"autism spectrum disorder\")",
      "concept": {
        "name": "autism spectrum disorder",
        "namespace": "DOID"
      },
      "function": "Pathology",
      "id": "03fe50e24458ee534f4ec1f73863bac1"
    },
    {
      "bel": "path(DOID:\"autoimmune disease of the nervous system\")",
      "concept": {
        "name": "autoimmune disease of the nervous system",
        "namespace": "DOID"
      },
      "function": "Pathology",
      "id": "4a7fb9119212ff279bec49357e313e58"
    },
    {
      "bel": "path(DOID:\"learning disability\")",
      "concept": {
        "name": "learning disability",
        "namespace": "DOID"
      },
      "function": "Pathology",
      "id": "4d1ef4744f637fe10df7019ecb69e2f4"
    },
    {
      "bel": "path(DOID:\"mental depression\")",
      "concept": {
        "name": "mental depression",
        "namespace": "DOID"
      },
      "function": "Pathology",
      "id": "444223db67421fa96923920d0a8fd533"
    },
    {
      "bel": "path(DOID:\"multiple sclerosis\")",
      "concept": {
        "name": "multiple sclerosis",
        "namespace": "DOID"
      },
      "function": "Pathology",
      "id": "828e65d53fe5c29b364f79cfd5304f90"
    },
    {
      "bel": "path(DOID:\"neurodegenerative disease\")",
      "concept": {
        "name": "neurodegenerative disease",
        "namespace": "DOID"
      },
      "function": "Pathology",
      "id": "9005fde45d3d20011ddb308da0266009"
    },
    {
      "bel": "path(DOID:\"neuromyelitis optica\")",
      "concept": {
        "name": "neuromyelitis optica",
        "namespace": "DOID"
      },
      "function": "Pathology",
      "id": "f639ff50800e42cbf0d8b6e0386b196f"
    },
    {
      "bel": "path(DOID:\"optic neuritis\")",
      "concept": {
        "name": "optic neuritis",
        "namespace": "DOID"
      },
      "function": "Pathology",
      "id": "791036b0fa3041ed717e835743f78526"
    },
    {
      "bel": "path(DOID:\"post-traumatic stress disorder\")",
      "concept": {
        "name": "post-traumatic stress disorder",
        "namespace": "DOID"
      },
      "function": "Pathology",
      "id": "8f3b588231081c24df8d180359e5c5a9"
    },
    {
      "bel": "path(DOID:\"relapsing-remitting multiple sclerosis\")",
      "concept": {
        "name": "relapsing-remitting multiple sclerosis",
        "namespace": "DOID"
      },
      "function": "Pathology",
      "id": "b21b34dd5c948d6330eceb5f4eb9649f"
    },
    {
      "bel": "path(DOID:\"rheumatic fever\")",
      "concept": {
        "name": "rheumatic fever",
        "namespace": "DOID"
      },
      "function": "Pathology",
      "id": "b948a412fb51f304069d5143ec9d3e2c"
    },
    {
      "bel": "path(DOID:\"secondary progressive multiple sclerosis\")",
      "concept": {
        "name": "secondary progressive multiple sclerosis",
        "namespace": "DOID"
      },
      "function": "Pathology",
      "id": "38f0567d9ceb0ade6bf93de56a897396"
    },
    {
      "bel": "path(DOID:\"sleep disorder\")",
      "concept": {
        "name": "sleep disorder",
        "namespace": "DOID"
      },
      "function": "Pathology",
      "id": "16b2af38a96cf5c3aed64dfd51512de6"
    },
    {
      "bel": "path(DOID:\"systemic lupus erythematosus\")",
      "concept": {
        "name": "systemic lupus erythematosus",
        "namespace": "DOID"
      },
      "function": "Pathology",
      "id": "055b0e91361e8cdf7def57c81e495fe1"
    },
    {
      "bel": "path(DOID:\"tic disorder\")",
      "concept": {
        "name": "tic disorder",
        "namespace": "DOID"
      },
      "function": "Pathology",
      "id": "e28afab868aa80c8f87488e90dff7481"
    },
    {
      "bel": "path(DOID:encephalitis)",
      "concept": {
        "name": "encephalitis",
        "namespace": "DOID"
      },
      "function": "Pathology",
      "id": "bc2e72167c0185ef49bf6eef35dc5880"
    },
    {
      "bel": "path(DOID:encephalomyelitis)",
      "concept": {
        "name": "encephalomyelitis",
        "namespace": "DOID"
      },
      "function": "Pathology",
      "id": "be497a57e1f1a82df51f35684a5499b5"
    },
    {
      "bel": "path(DOID:obesity)",
      "concept": {
        "name": "obesity",
        "namespace": "DOID"
      },
      "function": "Pathology",
      "id": "4fb5e37c4264c4147f39192b18900b32"
    },
    {
      "bel": "path(DOID:schizophrenia)",
      "concept": {
        "name": "schizophrenia",
        "namespace": "DOID"
      },
      "function": "Pathology",
      "id": "e8abd22302b97ee80e32edd14cf0f8fb"
    },
    {
      "bel": "path(HP:\"Abnormal proportion of CD4+ effector memory cells\")",
      "concept": {
        "name": "Abnormal proportion of CD4+ effector memory cells",
        "namespace": "HP"
      },
      "function": "Pathology",
      "id": "71f9d31c29231dfe9260d22c8daf45e4"
    },
    {
      "bel": "path(HP:\"Abnormality of movement\")",
      "concept": {
        "name": "Abnormality of movement",
        "namespace": "HP"
      },
      "function": "Pathology",
      "id": "5b10bb4085b259654f0d3aa3fb5be15d"
    },
    {
      "bel": "path(HP:\"Brain atrophy\")",
      "concept": {
        "name": "Brain atrophy",
        "namespace": "HP"
      },
      "function": "Pathology",
      "id": "ec0c8f7a450a01e4ab30fa28f040aed1"
    },
    {
      "bel": "path(HP:\"CNS demyelination\")",
      "concept": {
        "name": "CNS demyelination",
        "namespace": "HP"
      },
      "function": "Pathology",
      "id": "fb7670f43e6511eda6fbd0b0517820a6"
    },
    {
      "bel": "path(HP:\"Helicobacter pylori infection\")",
      "concept": {
        "name": "Helicobacter pylori infection",
        "namespace": "HP"
      },
      "function": "Pathology",
      "id": "955ba25880e823fc4d7b536aa8d82d44"
    },
    {
      "bel": "path(HP:\"Herpes simplex encephalitis\")",
      "concept": {
        "name": "Herpes simplex encephalitis",
        "namespace": "HP"
      },
      "function": "Pathology",
      "id": "0c999dcab51161e0b82167a92ab522e0"
    },
    {
      "bel": "path(HP:\"Memory impairment\")",
      "concept": {
        "name": "Memory impairment",
        "namespace": "HP"
      },
      "function": "Pathology",
      "id": "a7f2ce459c8b908cfa49f2dd08d8f075"
    },
    {
      "bel": "path(HP:\"Recurrent upper respiratory tract infections\")",
      "concept": {
        "name": "Recurrent upper respiratory tract infections",
        "namespace": "HP"
      },
      "function": "Pathology",
      "id": "ce70485ebf84bd5dbd2c355688e3d06f"
    },
    {
      "bel": "path(HP:\"Reduced proportion of naive T cells\")",
      "concept": {
        "name": "Reduced proportion of naive T cells",
        "namespace": "HP"
      },
      "function": "Pathology",
      "id": "f8f37d7c74590f9dcba625a84857423a"
    },
    {
      "bel": "path(HP:Agitation)",
      "concept": {
        "name": "Agitation",
        "namespace": "HP"
      },
      "function": "Pathology",
      "id": "db336c699f840cf5228a8a4a7eb05346"
    },
    {
      "bel": "path(HP:Autism)",
      "concept": {
        "name": "Autism",
        "namespace": "HP"
      },
      "function": "Pathology",
      "id": "674ebf9f3b4de23b7987883be2eff4d8"
    },
    {
      "bel": "path(HP:Autoimmunity)",
      "concept": {
        "name": "Autoimmunity",
        "namespace": "HP"
      },
      "function": "Pathology",
      "id": "a7fdebc3336d7daf8fa61b75a73d9fb0"
    },
    {
      "bel": "path(HP:Fatigue)",
      "concept": {
        "name": "Fatigue",
        "namespace": "HP"
      },
      "function": "Pathology",
      "id": "e398c9a963ab9c48ac72f9f35351cc80"
    },
    {
      "bel": "path(HP:Hemiparesis)",
      "concept": {
        "name": "Hemiparesis",
        "namespace": "HP"
      },
      "function": "Pathology",
      "id": "9abd8c6c941cad4d9ecf8178e74ccfd4"
    },
    {
      "bel": "path(HP:Mania)",
      "concept": {
        "name": "Mania",
        "namespace": "HP"
      },
      "function": "Pathology",
      "id": "bb713990f6a6cd9b538e7fd1b8326134"
    },
    {
      "bel": "path(HP:Paranoia)",
      "concept": {
        "name": "Paranoia",
        "namespace": "HP"
      },
      "function": "Pathology",
      "id": "37b794e8c02119ecbd6b72179fa9dbba"
    },
    {
      "bel": "path(HP:Psychosis)",
      "concept": {
        "name": "Psychosis",
        "namespace": "HP"
      },
      "function": "Pathology",
      "id": "02c61526fa6948f5f61e0e84922b586f"
    },
    {
      "bel": "path(MESH:\"Antiretroviral Therapy, Highly Active\")",
      "concept": {
        "name": "Antiretroviral Therapy, Highly Active",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "657988af54ef70e19c75a15e45d8c0c2"
    },
    {
      "bel": "path(MESH:\"Autoimmune Diseases\")",
      "concept": {
        "name": "Autoimmune Diseases",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "0aeb632260f15842cdd2b5e3c4b15c15"
    },
    {
      "bel": "path(MESH:\"Brain Injuries\")",
      "concept": {
        "name": "Brain Injuries",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "1ac8fcaca36bf2aee3bf5c9dfa8eca2c"
    },
    {
      "bel": "path(MESH:\"Cytomegalovirus Infections\")",
      "concept": {
        "name": "Cytomegalovirus Infections",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "71bf4ac22692545386c38e7fdc01f0f5"
    },
    {
      "bel": "path(MESH:\"HIV Infections\")",
      "concept": {
        "name": "HIV Infections",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "cb938c03c14b4963a9c2fbcbc4b290b4"
    },
    {
      "bel": "path(MESH:\"Hereditary Diffuse Leukoencephalopathy with Spheroids\")",
      "concept": {
        "name": "Hereditary Diffuse Leukoencephalopathy with Spheroids",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "bdc75db90c19224b379a1b21fe602034"
    },
    {
      "bel": "path(MESH:\"Illness Behavior\")",
      "concept": {
        "name": "Illness Behavior",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "1016c1344269747f632098ac52029e24"
    },
    {
      "bel": "path(MESH:\"Language Disorders\")",
      "concept": {
        "name": "Language Disorders",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "619153f2baea94f9174cc1c4763b5d7a"
    },
    {
      "bel": "path(MESH:\"Mental Disorders\")",
      "concept": {
        "name": "Mental Disorders",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "e8512811f7721057e47dbfde4f38eb20"
    },
    {
      "bel": "path(MESH:\"Mood Disorders\")",
      "concept": {
        "name": "Mood Disorders",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "623033cb1ec96120b0e159c16c359ac5"
    },
    {
      "bel": "path(MESH:\"Motor Disorders\")",
      "concept": {
        "name": "Motor Disorders",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "2e3b041e894813b580bde665989837d0"
    },
    {
      "bel": "path(MESH:\"Movement Disorders\")",
      "concept": {
        "name": "Movement Disorders",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "51d3c3e9dddddbccd7d7a538e7a23f73"
    },
    {
      "bel": "path(MESH:\"Neurocognitive Disorders\")",
      "concept": {
        "name": "Neurocognitive Disorders",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "bfda87ea9b56cb882e3b5ed0cfb1fe4a"
    },
    {
      "bel": "path(MESH:\"Neurodevelopmental Disorders\")",
      "concept": {
        "name": "Neurodevelopmental Disorders",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "b22e60c13f01081b15767008ad02b1ec"
    },
    {
      "bel": "path(MESH:\"Obsessive-Compulsive Disorder\")",
      "concept": {
        "name": "Obsessive-Compulsive Disorder",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "e902368b9756253cbe9d03b560616be3"
    },
    {
      "bel": "path(MESH:\"Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal infections\")",
      "concept": {
        "name": "Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal infections",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "56d279759e9024d499f89617b72f2f04"
    },
    {
      "bel": "path(MESH:\"Plaque, Amyloid\")",
      "concept": {
        "name": "Plaque, Amyloid",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "ff45c3caeb411cd232d96d6ed01854d5"
    },
    {
      "bel": "path(MESH:\"Psychosocial Deprivation\")",
      "concept": {
        "name": "Psychosocial Deprivation",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "b7c8c7b0c20ff049fc80cae71f924471"
    },
    {
      "bel": "path(MESH:\"Signs and Symptoms\")",
      "concept": {
        "name": "Signs and Symptoms",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "2f33eb498e2effe11a7b19d85ac16abe"
    },
    {
      "bel": "path(MESH:\"Social Behavior Disorders\")",
      "concept": {
        "name": "Social Behavior Disorders",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "a3a44e85681a23e74f833dc7cd773f69"
    },
    {
      "bel": "path(MESH:\"Social Behavior\")",
      "concept": {
        "name": "Social Behavior",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "63044439a8bfa188104a812e03dcb25a"
    },
    {
      "bel": "path(MESH:\"Social Isolation\")",
      "concept": {
        "name": "Social Isolation",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "6996cbe11809781667ce8f4dba02974e"
    },
    {
      "bel": "path(MESH:\"Streptococcal Infections\")",
      "concept": {
        "name": "Streptococcal Infections",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "340051dfcba46ee36d0abb0fca9dc312"
    },
    {
      "bel": "path(MESH:\"Systemic Inflammatory Response Syndrome\")",
      "concept": {
        "name": "Systemic Inflammatory Response Syndrome",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "8a8d91b2adbba140f2df83c3fc430a85"
    },
    {
      "bel": "path(MESH:\"Wallerian Degeneration\")",
      "concept": {
        "name": "Wallerian Degeneration",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "380f9d25f23839c3191109543af57b32"
    },
    {
      "bel": "path(MESH:Attention)",
      "concept": {
        "name": "Attention",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "f22e7196f5d0614ad79325e3690466ec"
    },
    {
      "bel": "path(MESH:Catatonia)",
      "concept": {
        "name": "Catatonia",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "113b7ede906ca5297a52e26b012fd99d"
    },
    {
      "bel": "path(MESH:Chorea)",
      "concept": {
        "name": "Chorea",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "da47c907ac04f2346024a244b33b9226"
    },
    {
      "bel": "path(MESH:Infection)",
      "concept": {
        "name": "Infection",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "572a317d84677724217aff971083c770"
    },
    {
      "bel": "path(MESH:Inflammation)",
      "concept": {
        "name": "Inflammation",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "10cd96fd4056a5e6c27264e0130e89f9"
    },
    {
      "bel": "path(MESH:Neuropsychiatry)",
      "concept": {
        "name": "Neuropsychiatry",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "7b8723f10a81d129ddc67282849f1ff5"
    },
    {
      "bel": "path(MESH:Pathology)",
      "concept": {
        "name": "Pathology",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "30821842828eae02c6e953a34f0cbf29"
    },
    {
      "bel": "path(MESH:Plasmapheresis)",
      "concept": {
        "name": "Plasmapheresis",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "98ae5c89246ca8e024c6cb8e2c5a970f"
    },
    {
      "bel": "path(MESH:Recurrence)",
      "concept": {
        "name": "Recurrence",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "aa96a379e06d692c47a017c1b23ad98f"
    },
    {
      "bel": "path(MESH:Toxoplasmosis)",
      "concept": {
        "name": "Toxoplasmosis",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "8e4b6b3fa74a1693391e2c2e1ead27aa"
    }
  ]
}